Clinical Center Home >> Collaborating with NIH Intramural Investigators at the Clinical Center >> Resources >> Rare Diseases >> Rare Disease Protocols

Why did you get here after a search? This site is offered to illustrate the special resources at the Clinical Center and to provide information on potential opportunities for collaboration. The disease for which you are searching is currently included in one or more protocols involving rare diseases at the NIH. To find the specific protocols, learn more about them, and get contact information for the principal investigator, use the search box on this page at right.

Other ways to navigate this page: You can sort each column alphabetically by ascending or descending order. Select the up and down arrows to the right of each column heading to reorder the information. Protocols can be shown 10, 25, 50 or 100 entries at a time. The Search box on this page will only search Rare Disease Protocols. You can search by disease name, protocol number and by keywords you might find in the protocol title.

Disease Name	Protocol Number	Protocol Title	Link
21-hydroxylase deficiency	96-CH-0033	An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children with Congenital Adrenal Hyperplasia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1996-CH-0033
21-hydroxylase deficiency	06-CH-0011	Natural History Study of Patients with Excess Androgen	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-CH-0011
Abetalipoproteinemia	76-H-0051	Lipoprotein Metabolism in Normal Volunteers and Hyperlipoproteinemic Patients	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1976-H-0051
Abrikosov's tumor	10-C-0111	Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN) ChildrenÕs Oncology Group	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0111
21-hydroxylase deficiency	09-I-0102	Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-I-0102
Acanthocheilonemiasis	88-I-0083	Host Response to Infection and Treatment in the Filarial Diseases of Humans	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1988-I-0083
Acanthosis nigricans	76-DK-0006	Studies of Molecular Genetics of Insulin Secretion, Insulin Action, and Diabetes Mellitus	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1976-DK-0006
Acoustic neuroma	11-C-0115	Phase 2 Study of Bevacizumab in Children and Adults with Neurofibromatosis Type 2 and Symptomatic Vestibular Schwannoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0115
Acoustic neuroma	10-N-0193	Using Positron Emission Tomography (PET) to Predict Intracranial Tumor Growth in Neurofibromatosis Type II (NF2) Patients	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-N-0193
Acoustic neuroma	08-N-0044	A Prospective Natural History Study of Patients with Neurofibromatosis Type 2 (NF2)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-N-0044
Acromegaly	85-DK-0082	Acromegaly Treatment and Natural History	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1985-DK-0082
ACTH deficiency	05-CH-0013	Adrenal Function in Critical Illness	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-CH-0013
Acute lymphoblastic leukemia	11-C-0136	Multi-Institutional Prospective Pilot Study of Lupron to Enhance Lymphocyte Immune Reconstitution Following Allogeneic Bone Marrow Transplantation in Post-Pubertal Children and Adults with Molecular Imaging Evaluation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0136
Acute lymphoblastic leukemia	10-C-0220	Phase I Trial to Evaluate the Safety, Activity and Pharmacokinetics of Marqibo¨ (Vincristine Sulfate Liposomes Injection) in Children and Adolescents with Refractory Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0220
Acute lymphoblastic leukemia	10-C-0054	Administration of Anti-CD19-Chimeric-Antigen-Receptor-Transduced T-cells from the Original Transplant Donor to Patients with Recurrent or Persistent B-Cell Malignancies After Allogeneic Stem Cell Transplantation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0054
Acute lymphoblastic leukemia	09-H-0087	Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0087
Acute lymphoblastic leukemia	08-C-0123	A Phase 1, Multi-Center, Dose Escalation Study of CAT-8015 in Children, Adolescents, and Young Adults with Refractory CD22+ Acute Lymphoblastic Leukemia (ALL) or Non-HodgkinÕs Lymphoma (NHL)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0123
Acute lymphoblastic leukemia	08-C-0051	A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0051
Acute lymphoblastic leukemia	07-H-0091	WTI Peptide Vaccination for Patients with High Risk Hematological Malignancies
Acute lymphoblastic leukemia	06-H-0248	Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using a Positive Stem Cell Selection Technique for T Cell Depletion, Followed by Delayed T Cell Add-Back	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-H-0248
Acute lymphoblastic leukemia	06-C-0233	A Phase I/II Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0233
Acute lymphoblastic leukemia	04-H-0112	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Peritransplant Cyclosporine on Chimerism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-H-0112
Acute lymphoblastic leukemia	03-H-0192	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies Ã? Effect of Irradiated Donor Lymphocytes on Chimerism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-H-0192
Acute lymphoblastic leukemia	01-C-0125	Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0125
Acute lymphoblastic leukemia	99-H-0050	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-H-0050
Acute lymphoblastic leukemia	99-H-0046	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine
Acute lymphoblastic leukemia	11-C-0125	Relapsed Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation: Screening, Disease Characterization and Natural History	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0125
Acute lymphoblastic leukemia	10-C-0066	Collection of Human Samples to Study Hairy Cell and Other Leukemias and to Develop Recombinant Immunotoxins for Cancer Treatment	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0066
Acute lymphoblastic leukemia	04-C-0102	Hematologic Malignancy Biology Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0102
Acute lymphoblastic leukemia	08-C-0123	A Phase 1, Multi-Center, Dose Escalation Study of CAT-8015 in Children, Adolescents, and Young Adults with Refractory CD22+ Acute Lymphoblastic Leukemia (ALL) or Non-HodgkinÕs Lymphoma (NHL)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0123
Acute myelocytic leukemia	03-H-0192	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies Ã? Effect of Irradiated Donor Lymphocytes on Chimerism
Acute myeloid leukemia, adult	11-C-0136	Multi-Institutional Prospective Pilot Study of Lupron to Enhance Lymphocyte Immune Reconstitution Following Allogeneic Bone Marrow Transplantation in Post-Pubertal Children and Adults with Molecular Imaging Evaluation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0136
Acute myeloid leukemia, adult	09-H-0087	Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0087
Acute myeloid leukemia, adult	09-C-0096	Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0096
Acute myeloid leukemia, adult	08-C-0051	A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0051
Acute myeloid leukemia, adult	07-H-0136	Selective Depletion of Alloreacting T Cells Using a Photodepletion Technique to Prevent GVHD after HLA-Matched Peripheral Blood Stem Cell Transplantation for Subjects with Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-H-0136
Acute myeloid leukemia, adult	07-H-0091	WTI Peptide Vaccination for Patients with High Risk Hematological Malignancies
Acute myeloid leukemia, adult	06-H-0248	Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using a Positive Stem Cell Selection Technique for T Cell Depletion, Followed by Delayed T Cell Add-Back	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-H-0248
Acute myeloid leukemia, adult	06-C-0152	Phase I Trial of CEDIRANIB (AZD2171), an Orally Bioavailable Antiangiogenic Agent, in Children and Adolescents with Refractory or Recurrent Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0152
Acute myeloid leukemia, adult	01-C-0125	Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0125
Acute myeloid leukemia, adult	99-H-0050	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-H-0050
Acute myeloid leukemia, adult	99-H-0046	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine
Acute myeloid leukemia, adult	11-C-0125	Relapsed Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation: Screening, Disease Characterization and Natural History	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0125
Acute myeloid leukemia, adult	04-C-0102	Hematologic Malignancy Biology Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0102
Acute respiratory distress syndrome	08-I-0093	A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Topical Nasal Poly-ICLC
Acute respiratory distress syndrome	05-CC-0012	Effects of Inhaled Carbon Monoxide on Pulmonary Inflammatory Responses Following Endotoxin Instillation
Adenocarcinoma of lung	10-C-0032	A Phase I Trial of SS1 (dsFv) PE38 with Paclitaxel, Carboplatin, and Bevacizumab in Subjects with Unresectable Non-Small Cell Lung Adenocarcinoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0032
Adenocarcinoma of lung	10-C-0170	Lung Cancer Mutation Consortium Protocol	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0170
Adenocarcinoma of the appendix	00-C-0069	Phase II Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) with Cisplatin plus Early Postoperative Intraperitoneal Paclitaxel and 5-Fluorouracil for Peritoneal Carcinomatosis
Adenoid cystic carcinoma	11-C-0038	A Phase 2 Study of Vorinostat in Subjects with Locally Advanced, Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) (IND 71976)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0038
Adenoma of the adrenal gland	00-CH-0160	Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-CH-0160
Adenosine deaminase deficiency	01-HG-0189	Treatment of SCID due to ADA Deficiency with Autologous Cord Blood or Bone Marrow CD34+ Cells Transduced with a Human ADA Gene	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-HG-0189
Adenosine deaminase deficiency	01-H-0198	Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-H-0198
Adenosine deaminase deficiency	00-HG-0209	Molecular and Clinical Studies of Primary Immunodeficiency Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-HG-0209
Adenosine deaminase deficiency	10-HG-0151	Quality of Life and Neuropsychiatric Sequelae in Patients Treated with Gene Therapy for ADA-SCID and in their Parents	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-HG-0151
Adrenal cancer	10-C-0078	A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0078
Adrenal cancer	09-C-0089	A Targeted Ph I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ¨), in Adults with Solid Tumors with a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Ca (MTC)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0089
Adrenal cancer	04-C-0177	A Pilot Study of Tc-94m Sestamibi PET MDR Imaging	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0177
Adrenal cancer	11-C-0149	Evaluation of Diagnostic and Prognostic Molecular Markers in Adrenal Neoplasm	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0149
Adrenal cancer	00-CH-0160	Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-CH-0160
Adrenal cancer	09-C-0242	Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0242
Adrenocortical carcinoma	10-C-0203	Phase II Study of Axitinib (AG-013736) with Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0203
Adrenocortical carcinoma	11-C-0149	Evaluation of Diagnostic and Prognostic Molecular Markers in Adrenal Neoplasm	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0149
Adrenocortical carcinoma	00-CH-0160	Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-CH-0160
AIDS Dementia Complex	07-M-0129	PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using (11C)PBR28 in HIV-Seropositive Patients with (MCMD)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-M-0129
Albinism	07-HG-0132	Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-HG-0132
Albinism	97-HG-0085	Therapeutic Clinical Trial of Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-HG-0085
Albinism	09-HG-0035	Clinical, Cellular, and Molecular Investigations into Oculocutaneous Albinism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-HG-0035
Albinism	00-HG-0153	Investigations into Chediak-Higashi Syndrome and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-HG-0153
Albinism	95-HG-0193	Clinical and Basic Investigations into Hermansky-Pudlak Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-HG-0193
Alkaptonuria	05-HG-0076	Long-Term Clinical Trial of Nitisinone in Alkaptonuria
Alkaptonuria	00-HG-0141	Clinical, Biochemical, and Molecular Investigations into Alkaptonuria	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-HG-0141
Alpha 1-antitrypsin deficiency	96-H-0100	Role of Genetic Factors in the Pathogenesis of Lung Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1996-H-0100
Alstrom syndrome	03-HG-0264	Clinical Investigations into the Kidney and Liver Disease in Autosomal Recessive Polycystic Kidney Disease/Congenital Hepatic Fibrosis and other Ciliopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-HG-0264
Alveolar soft part sarcoma	09-C-0192	Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0192
Alveolar soft part sarcoma	08-C-0080	SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0080
Amebiasis	77-I-0094	Study of Patients with Parasitic Infections of the Gastrointestinal Tract	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1977-I-0094
Amyotrophic lateral sclerosis	11-M-0087	Efficacy and Tolerability of Riluzole and Biomarker of Treatment Response in Treatment-Resistant Depression	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-M-0087
Amyotrophic lateral sclerosis	10-N-0121	Oxidative Stress in Motor Neuron Disease: COSMOS-PLS Add-On Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-N-0121
Amyotrophic lateral sclerosis	06-N-0174	Cortical Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-N-0174
Amyotrophic lateral sclerosis	06-N-0224	Collection of Blood Samples for DNA Analysis in Motor Neuron Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-N-0224
Anal cancer	11-C-0129	A Pilot Trial Assessing the Feasibility of Delivering Topical MTS-01 to Reduce Dermatitis in Patients Receiving Intensity Modulated Radiation with Concurrent 5-Fluorouracil and Mitomycin-C for Stage I-III Carcinoma of the Anal Canal	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0129
Anaplastic astrocytoma	11-C-0122	Phase I Trial of AZD8055, An Oral MTOR Kinase Inhibitor, for Adults with Recurrent Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0122
Anaplastic astrocytoma	10-C-0219	A Phase I Trial of Lenalidomide and Radiotherapy in Children with Diffuse Intrinsic Pontine Gliomas and High-grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0219
Anaplastic astrocytoma	09-C-0222	A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination with Carboplatin versus Carboplatin Alone Followed by Vandetanib Alone in Adults with Recurrent High-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0222
Anaplastic astrocytoma	09-C-0080	A Phase 2, Open-label, Proof-of-Concept Study to Assess the Ability to Detect Tumours and Angiogenesis via the Expression of Alpha v Beta 3 Integrin Receptors by (18F)AH-111585 PET Imaging	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0080
Anaplastic astrocytoma	08-C-0101	A Phase 2 Trial of Tandutinib in Combination with Bevacizumab for Patients with Recurrent High-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0101
Anaplastic astrocytoma	08-C-0015	A Phase II Trial of Enzastaurin (LY317615) in Combination with Bevacizumab in Adults with Recurrent Malignant Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0015
Anaplastic astrocytoma	03-C-0002	A Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron(TM)) and Thalidomide in Adults with Recurrent High-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-C-0002
Anaplastic astrocytoma	11-C-0081	(11C)N-Desmethyl-Loperamide as a Marker of P-Glycoprotein Function in Patients with Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0081
Anaplastic astrocytoma	11-C-0036	A Pilot Study of Inpatient Hospice with Procurement of Brain Tumor Tissue on Expiration for Research Purposes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0036
Anaplastic large cell lymphoma	10-C-0178	A Phase 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0178
Anaplastic large cell lymphoma	04-C-0173	Phase II Study of UCN-01 in Relapsed or Refractory Systemic Anaplastic Large Cell and Mature T-Cell Lymphomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0173
Anaplastic large cell lymphoma	93-C-0133	Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Patients with Aggressive Non-Hodgkin's Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1993-C-0133
Anaplastic oligodendroglioma	11-C-0122	Phase I Trial of AZD8055, An Oral MTOR Kinase Inhibitor, for Adults with Recurrent Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0122
Anaplastic oligodendroglioma	08-C-0101	A Phase 2 Trial of Tandutinib in Combination with Bevacizumab for Patients with Recurrent High-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0101
Anaplastic oligodendroglioma	08-C-0015	A Phase II Trial of Enzastaurin (LY317615) in Combination with Bevacizumab in Adults with Recurrent Malignant Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0015
Anaplastic oligodendroglioma	03-C-0002	A Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron(TM)) and Thalidomide in Adults with Recurrent High-Grade Gliomas
Anaplastic oligodendroglioma	11-C-0081	(11C)N-Desmethyl-Loperamide as a Marker of P-Glycoprotein Function in Patients with Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0081
Anaplastic oligodendroglioma	11-C-0036	A Pilot Study of Inpatient Hospice with Procurement of Brain Tumor Tissue on Expiration for Research Purposes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0036
Aniridia	08-CH-0213	WAGR Syndrome and Other 11p Contiguous Gene Deletions: Clinical Characterization and Correlation with Genotype	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-CH-0213
Anthrax	04-CH-0283	Anthrax Vaccine Clinical Trials	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-CH-0283
Anthrax	02-I-0110	Natural History of Anthrax: A Study of Primary Infected, Recovered, and Exposed (SPoRE) Individuals and Evaluation of AVA Vaccinated Recipients	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-I-0110
Aplastic anemia	11-H-0134	A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Moderate Aplastic Anemia Patients	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-H-0134
Aplastic anemia	10-H-0177	A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-H-0177
Aplastic anemia	10-H-0176	Cyclophosphamide Plus Cyclosporine in Treatment-Na•ve Severe Aplastic Anemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-H-0176
Aplastic anemia	10-H-0154	Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused with a Reduced Dose of Non-Mobilized Donor T-Cells	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-H-0154
Aplastic anemia	09-H-0183	Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or with a Suboptimal Response to Rabbit ATG/CsA Treatment	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0183
Aplastic anemia	09-H-0154	A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients with Immunosuppressive-Therapy Refractory Thrombocytopenia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0154
Aplastic anemia	08-H-0046	Co-Infusion of Umbilical Cord Blood and Haploidentical CD34+ Cells Following Nonmyeloablative Conditioning as Treatment for Severe Aplastic Anemia and MDS Associated with Severe Neutropenia Refractory to Immunosuppressive Therapy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-H-0046
Aplastic anemia	08-CH-0022	Treatment of Menorrhagia in Women with Thrombocytopenia: Comparison of Platelet Transfusion Alone to Platelet Transfusion with Continuous Oral Contraceptive Pills	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-CH-0022
Aplastic anemia	06-H-0034	A Randomized Study of Three Immunosuppressive Regimens in Treatment Naive Patients with Severe Aplastic Anemia: Horse ATG/CsA Taper vs Rabbit-ATG/CsA vs Alemtuzumab	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-H-0034
Aplastic anemia	05-H-0242	A Pilot Study of Alemtuzumab (Campath) in Patients with Relapsed or Refractory Severe Aplastic Anemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-H-0242
Aplastic anemia	05-H-0206	A Pilot Study of Alemtuzumab (Campath[R]) in Patients with Myelodysplastic Syndrome (MDS)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-H-0206
Aplastic anemia	03-H-0249	A Randomized Trial of Immunosupression in Aplastic Anemia Patients with Refractory Pancytopenia or Suboptimal Hematologic Response after h-ATG/CsA Treatment	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-H-0249
Aplastic anemia	03-H-0193	A Randomized Trial of a Novel Immunosuppressive Combination of ATG, CsA and Sirolimus (Rapamune) vs a Slow Taper Cyclosporine Regimen in Subjects with Severe Aplastic Anemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-H-0193
Aplastic anemia	00-H-0169	A Phase II Study of Antithymocyte Globulin (ATG) and Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)
Aplastic anemia	00-H-0032	Treatment of Severe Aplastic Anemia with Combined Immunosuppression: Antithymocyte Globulin (ATG) and Cyclosporine A (CSA), and Mycophenolate Mofetil (MMF)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-H-0032
Aplastic anemia	00-H-0029	A Pilot Study of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) in Patients with Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia	http://clinicalstudies.info.nih.gov/cgi/wais/bold032001.pl?B_00-H-0029.html@00-H-0029
Aplastic anemia	99-H-0050	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-H-0050
Aplastic anemia	97-H-0117	A Randomized Trial of Antithymocyte Globulin and Cyclosporine versus Cyclophosphamide and Cyclosporine in the Treatment of Severe Aplastic Anemia
Aplastic anemia	04-H-0213	Cytokine Gene Polymorphisms in Bone Marrow Failure
Aplastic anemia	03-H-0051	Collection of Blood, Stool, Bone Marrow and/or Tissue Samples from Subjects with Hepatitis-Associated Aplastic Anemia
Aplastic anemia	02-C-0052	Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0052
Aplastic anemia	01-C-0144	Surveillance of Invasive Fungal Infections in Bone Marrow/Stem Cell and Solid Organ Transplantation Recipients and Other Immunocompromised Patients: A Prospective Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0144
Aplastic anemia	97-H-0130	Collection of Blood and Bone Marrow from Healthy Volunteers and Patients for Research Purposes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-H-0130
Aplastic anemia	86-H-0088	Lymphocytapheresis of Patients with Pancytopenia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1986-H-0088
Aplastic anemia	08-H-0222	Neuropsychological Effects of Immunosuppressive Treatment in Subjects with Aplastic Anemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-H-0222
Arachnoid cysts	01-N-0085	Establishing the Pathophysiology of Primary Spinal Syringomyelia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-N-0085
Arachnoiditis	01-N-0085	Establishing the Pathophysiology of Primary Spinal Syringomyelia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-N-0085
Auditory perceptual disorder	00-DC-0073	Identification of Hereditary Auditory Temporal Processing Deficits	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-DC-0073
Auditory perceptual disorder	10-DC-0211	Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-DC-0211
Autoimmune hemolytic anemia	97-C-0178	Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-C-0178
Autoimmune lymphoproliferative syndrome	08-I-0053	Pilot (Phase I-II) Study of Valproic Acid (Depakote) for the Treatment of the Autoimmune Lymphoproliferative Syndrome (ALPS)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-I-0053
Autoimmune lymphoproliferative syndrome	02-I-0308	Study of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for the Evaluation of the Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-Associated Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-I-0308
Autoimmune lymphoproliferative syndrome	93-I-0063	Study of the Immunopathogenesis, Natural History, and Genetics of Autoimmune Lymphoproliferative Syndrome (ALPS) Associated with an Expansion of CD4-8-/TCR alpha/beta+ T Cells	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1993-I-0063
Autoimmune oophoritis	92-CH-0223	Autoimmune Premature Ovarian Failure: A Controlled Trial of Alternate-Day Prednisone Therapy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1992-CH-0223
Autosomal dominant hyper IgE syndrome	07-I-0218	A Double-Blind, Randomized, Placebo-Controlled Cross-Over Study Assessing the Role of Pathogen-Specific IgE and Histamine Release in the Hyper-IgE Syndrome and the Effect of Ranitidine on Laboratory and Clinical Manifestations	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-I-0218
Autosomal dominant hyper IgE syndrome	01-I-0202	Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0202
Autosomal recessive polycystic kidney disease	03-HG-0264	Clinical Investigations into the Kidney and Liver Disease in Autosomal Recessive Polycystic Kidney Disease/Congenital Hepatic Fibrosis and other Ciliopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-HG-0264
Bardet-Biedl syndrome	03-HG-0264	Clinical Investigations into the Kidney and Liver Disease in Autosomal Recessive Polycystic Kidney Disease/Congenital Hepatic Fibrosis and other Ciliopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-HG-0264
Bardet-Biedl syndrome	04-HG-0123	Bardet-Biedl Syndrome: Phenotype and Metabolic Characteristics	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-HG-0123
B-cell lymphomas	10-C-0011	Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0011
B-cell lymphomas	07-H-0136	Selective Depletion of Alloreacting T Cells Using a Photodepletion Technique to Prevent GVHD after HLA-Matched Peripheral Blood Stem Cell Transplantation for Subjects with Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-H-0136
B-cell lymphomas	05-C-0252	Phase III Randomized Study of R-CHOP v. Dose-Adjusted EPOCH-R with Molecular Profiling in Untreated de Novo Diffuse Large B-Cell Lymphomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-C-0252
Behcet's disease	10-AR-0182	A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome (FCAS) / Muckle-Wells Syndrome (MWS) and BehcetÕs Disease (BD)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-AR-0182
Behcet's disease	03-AR-0173	Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CRMO, StillÕs Disease, BehcetÕs Disease, and other Undifferentiated Autoinflammatory Diseases)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-AR-0173
Behcet's disease	10-EI-0093	Immunogenetic Mechanisms in Behcet's Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-EI-0093
Benign essential tremor syndrome	09-N-0084	Double-Blind, Placebo Controlled Pilot-Study of Octanoic Acid in Essential Tremor
Benign essential tremor syndrome	10-N-0199	Ethanol Response in Essential Tremor: Clinical and Neurophysiological Correlates	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-N-0199
Benign essential tremor syndrome	01-N-0206	Phenotype/Genotype Correlations in Movement Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-N-0206
Benign essential tremor syndrome	85-N-0195	A Training Protocol for the use of Botulinum Toxin in the Treatment of Neurological Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1985-N-0195
Beta-thalassemia	05-H-0019	A Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis
Bietti crystalline corneoretinal dystrophy	05-EI-0143	Molecular Genetics of Retinal Degenerations	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-EI-0143
Biotinidase deficiency	10-I-0216	Studies of Disorders with Increased Susceptibility to Fungal Infections	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0216
Birt-Hogg-Dube syndrome	02-C-0159	The Birt Hogg-Dube Syndrome: Identification of the Disease Gene and Characterization of the Predisposition of Renal Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0159
Birt-Hogg-Dube syndrome	89-C-0086	Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-C-0086
Blastoma	11-C-0034	Dicer1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0034
Blepharospasm	07-N-0165	Suppression and Facilitation of the Motor Cortex by Stimulation of the Cerebellum in Patients with Dystonia and Healthy Controls	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-N-0165
Bone cancer	10-C-0030	A Study of Bevacizumab, a Humanized Monoclonal Antibody Against Vascular Endothelial Growth Factor (VEGF), in Combination with Chemotherapy for Treatment of Osteosarcoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0030
Bronchiolitis obliterans	11-H-0068	Phase II Trial of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for Treatment of Bronchiolitis Obliterans	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-H-0068
Bronchiolitis obliterans	11-H-0064	Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-H-0064
Bronchiolitis obliterans	08-C-0097	Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic or Autologous Stem Cell Transplantation in Children and Adults	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0097
Bulbo-spinal atrophy X-linked	06-N-0113	Phase II Clinical Trial to Examine the Efficacy and Safety of Dutasteride in Patients with Kennedy's Disease (Spinal and Bulbar Muscular Atrophy)
Burkitt's lymphoma	10-C-0052	Phase II Study of Dose-Adjusted EPOCH+/-Rituximab in Adults with Untreated Burkitt Lymphoma, c-MYC Positive Diffuse Large B-Cell Lymphoma and Plasmablastic Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0052
Carcinoid tumor	08-DK-0098	Natural History of Familial Carcinoid Tumor	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-DK-0098
Carcinoid tumor	93-DK-0127	Family Studies in Metabolic Diseases and Mineral Metabolism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1993-DK-0127
Carcinoma, squamous cell	10-D-0180	A Pilot Trial Targeting mTOR as a Novel Mechanism-Based Neoadjuvant Therapy for Head and Neck Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-D-0180
Carney complex	95-CH-0059	Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-CH-0059
Castleman's disease	04-C-0275	Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease with Laboratory and Clinical Correlates of Disease Activity	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0275
Central serous chorioretinopathy	11-EI-0012	Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-EI-0012
Cerebellar ataxia	08-N-0153	The Role of Autoimmunity in Neurologic Complications of Celiac Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-N-0153
Cerebellar degeneration, subacute	09-H-0225	Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Beta-Thalassemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0225
Ceroid lipofuscinosis neuronal 3	01-CH-0086	A Combination Therapy with Cystagon and N-Acetylcysteine for INCL Patients	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-CH-0086
Cervical dystonia	85-N-0195	A Training Protocol for the use of Botulinum Toxin in the Treatment of Neurological Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1985-N-0195
Chagas disease	97-I-0096	Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-I-0096
Chediak-Higashi syndrome	04-HG-0226	Investigations of Megakaryocytes from Patients with Abnormal Platelet Vesicles	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-HG-0226
Chediak-Higashi syndrome	00-HG-0153	Investigations into Chediak-Higashi Syndrome and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-HG-0153
CHILD syndrome	02-CH-0311	Investigations into Inborn Errors of Cholesterol Synthesis and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-CH-0311
Childhood-Onset Schizophrenia	97-M-0126	Childhood Onset Psychotic Disorders: Characterization and Treatment with Atypical Neuroleptics
Chondrodysplasia	02-CH-0311	Investigations into Inborn Errors of Cholesterol Synthesis and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-CH-0311
Chondrodysplasia	02-CH-0311	Investigations into Inborn Errors of Cholesterol Synthesis and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-CH-0311
Chordoma	78-C-0039	Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1978-C-0039
Chromosome 8, trisomy	07-H-0225	A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients with RAEB-1 AND RAEB-2 Myelodysplastic Syndrome (MDS) and AML with Trisomy 8	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-H-0225
Chronic granulomatous disease	10-I-0123	Assessment of the Biochemical Response to Interferon-Gamma in Subjects with Specific Gene Mutation in Chronic Granulomatous Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0123
Chronic granulomatous disease	07-I-0075	Allogeneic and Matched Unrelated Donor Stem Cell Transplantation for Congenital Immunodeficiencies: Busulfan-Based Conditioning with Campath- 1H or h-ATG, Radiation, and Sirolimus	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-I-0075
Chronic granulomatous disease	07-I-0017	Autologous Transplantation of Genetically Modified Cells for the Treatment of X-Linked Chronic Granulomatous Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-I-0017
Chronic granulomatous disease	06-I-0160	Tumor Necrosis Factor Alpha Inhibitor (lnfliximab, Adalimumab) Treatment for Crohn's-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-I-0160
Chronic granulomatous disease	10-I-0216	Studies of Disorders with Increased Susceptibility to Fungal Infections	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0216
Chronic granulomatous disease	10-I-0029	Non-Invasive Assessment of Atherosclerosis in Patients with CGD and Other Disorders of the Immune System	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0029
Chronic granulomatous disease	06-I-0217	Genetic Disorders of Mucociliary Clearance	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-I-0217
Chronic granulomatous disease	94-I-0073	Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-I-0073
Chronic granulomatous disease	82-I-0183	Study of the Immune Regulation of Idiopathic Inflammatory Bowel Diseases: Crohn's Disease, Ulcerative Colitis, and Other Inflammatory Conditions of the Gut	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1982-I-0183
Chronic granulomatous disease	07-I-0142	Research Respiratory Tract Procedures	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-I-0142
Chronic granulomatous disease	07-I-0033	Screening Protocol for Detection and Characterization of Infections and Infection Susceptibility	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-I-0033
Chronic granulomatous disease	05-I-0213	Screening and Baseline Assessment of Patients with Abnormalities of Immune Function	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-I-0213
Chronic Infantile Neurological Cutaneous Articular syndrome	09-AR-0006	A Multi-Center, Open Label, 24-Month Treatment Study to Establish the Safety, Tolerability, Efficacy, Pharmacokinetics of Canakinumab (anti-IL-1 Beta Antibody) in Patients with NOMID / CINCA Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-AR-0006
Chronic Infantile Neurological Cutaneous Articular syndrome	05-AR-0014	Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects with Autoinflammatory Disease: A Therapeutic Approach to Study Pathogenesis
Chronic Infantile Neurological Cutaneous Articular syndrome	03-AR-0298	A Long-Term Outcome Study with the IL-1 Receptor Antagonist anakinra/Kineret¨ in Patients with Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome) A Therapeutic Approach to Study the Pathogenesis of this Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-AR-0298
Chronic Infantile Neurological Cutaneous Articular syndrome	03-AR-0173	Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CRMO, StillÕs Disease, BehcetÕs Disease, and other Undifferentiated Autoinflammatory Diseases)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-AR-0173
Chronic lymphocytic leukemia	09-C-0043	A Single-Dose Study Evaluating the Oral Bioavailability and Pharmacokinetics of the Capsule Formulation of ABT-263 in Subjects with Cancer
Chronic lymphocytic leukemia	10-H-0141	A Phase II Study of Ofatumumab-Based Induction Chemoimmunotheraphy Followed by Consolidation Ofatumumab Immunotherapy in Previously Untreated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-H-0141
Chronic lymphocytic leukemia	10-C-0067	A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0067
Chronic lymphocytic leukemia	09-H-0094	A Pilot Study of the Safety and Efficacy of Escalating Doses of ON 01910.Na in Patients with Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0094
Chronic lymphocytic leukemia	09-H-0087	Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0087
Chronic lymphocytic leukemia	09-C-0224	Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0224
Chronic lymphocytic leukemia	09-C-0210	Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0210
Chronic lymphocytic leukemia	09-C-0082	Assessment of the Safety and Feasibility of Administering T Cells Expressing an anti-CD19 Chimeric Antigen Receptor to Patients with B-cell Lymphoma or Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0082
Chronic lymphocytic leukemia	09-C-0048	A Phase I Study of ABT-888 in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0048
Chronic lymphocytic leukemia	08-H-0186	Safety and the Anti-Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NKÃ?TRAIL Cytotoxicity with Bortezomib	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-H-0186
Chronic lymphocytic leukemia	08-C-0091	Phase I Study of SNX-5422 Mesylate in Adults with Refractory Solid Tumor Malignancies and Lymphomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0091
Chronic lymphocytic leukemia	07-H-0136	Selective Depletion of Alloreacting T Cells Using a Photodepletion Technique to Prevent GVHD after HLA-Matched Peripheral Blood Stem Cell Transplantation for Subjects with Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-H-0136
Chronic lymphocytic leukemia	07-H-0104	A Phase II Study of Lenalidomide Revlimid¨ in Previously Treated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic lymphocytic leukemia	07-C-0203	A Phase I Study of ABT-888 in Combination with Topotecan Hydrochloride in Adults with Refractory Solid Tumors and Lymphomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0203
Chronic lymphocytic leukemia	07-C-0195	Pilot Trial of Targeted Immune-Depleting Chemo & Reduced-Intensity Allo Hematopoietic SCT Using 8/8 & 7/8 HLA-Matched Unrelated Donors and Utilizing 2 GVHD Prophy Regimens for the Tx of Leukemias, Lymphomas, & Pre-Malignant Blood Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0195
Chronic lymphocytic leukemia	07-C-0081	A Phase I/II Study of Flavopiridol in Relapsed or Refractory Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma (DLBCL)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0081
Chronic lymphocytic leukemia	07-C-0064	Adoptive Cell Therapy for B-Cell Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation with Costimulated, Tumor-Derived Lymphocytes
Chronic lymphocytic leukemia	06-H-0248	Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using a Positive Stem Cell Selection Technique for T Cell Depletion, Followed by Delayed T Cell Add-Back	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-H-0248
Chronic lymphocytic leukemia	06-H-0190	Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders with Alemtuzumab (Campath)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-H-0190
Chronic lymphocytic leukemia	06-C-0227	Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0227
Chronic lymphocytic leukemia	04-H-0112	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Peritransplant Cyclosporine on Chimerism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-H-0112
Chronic lymphocytic leukemia	04-C-0121	A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Chronic Lymphocytic Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0121
Chronic lymphocytic leukemia	03-H-0192	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies Ã? Effect of Irradiated Donor Lymphocytes on Chimerism
Chronic lymphocytic leukemia	01-H-0162	Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Using RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched, Nonmyeloablative, Peripheral Blood Stem Cell Transplantation for H
Chronic lymphocytic leukemia	01-C-0235	Combination Antibody Therapy with Apolizumab (1D10) and Rituximab (CD20) in Relapsed Lymphoma and CLL
Chronic lymphocytic leukemia	99-H-0050	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-H-0050
Chronic lymphocytic leukemia	99-H-0046	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine
Chronic lymphocytic leukemia	99-C-0143	Pilot Study of Donor Th2 Cells for the Prevention of Graft-Versus-Host Disease in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-C-0143
Chronic lymphocytic leukemia	97-H-0202	Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults
Chronic lymphocytic leukemia	97-C-0178	Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-C-0178
Chronic lymphocytic leukemia	10-H-0097	A Study of the Kinetics of Lymphoid Cells in Patients with Monoclonal B-Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers.	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-H-0097
Chronic lymphocytic leukemia	10-C-0066	Collection of Human Samples to Study Hairy Cell and Other Leukemias and to Develop Recombinant Immunotoxins for Cancer Treatment	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0066
Chronic lymphocytic leukemia	08-H-0105	Natural History Study of Monoclonal B Cell Lymphocytosis (MBL) and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-H-0105
Chronic myeloid leukemia	09-C-0210	Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0210
Chronic myeloid leukemia	08-H-0186	Safety and the Anti-Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NKÃ?TRAIL Cytotoxicity with Bortezomib	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-H-0186
Chronic myeloid leukemia	08-C-0051	A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0051
Chronic myeloid leukemia	07-H-0159	Efficacy of WT1 and PRI Peptide Vaccination for Patients with Low Risk Myeloid Malignancies
Chronic myeloid leukemia	07-H-0136	Selective Depletion of Alloreacting T Cells Using a Photodepletion Technique to Prevent GVHD after HLA-Matched Peripheral Blood Stem Cell Transplantation for Subjects with Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-H-0136
Chronic myeloid leukemia	07-H-0091	WTI Peptide Vaccination for Patients with High Risk Hematological Malignancies
Chronic myeloid leukemia	07-C-0195	Pilot Trial of Targeted Immune-Depleting Chemo & Reduced-Intensity Allo Hematopoietic SCT Using 8/8 & 7/8 HLA-Matched Unrelated Donors and Utilizing 2 GVHD Prophy Regimens for the Tx of Leukemias, Lymphomas, & Pre-Malignant Blood Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0195
Chronic myeloid leukemia	06-H-0248	Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using a Positive Stem Cell Selection Technique for T Cell Depletion, Followed by Delayed T Cell Add-Back	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-H-0248
Chronic myeloid leukemia	06-H-0062	Safety of WT1 and PR1 Peptide Vaccination for Patients with Myeloid Malignancies
Chronic myeloid leukemia	06-C-0233	A Phase I/II Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0233
Chronic myeloid leukemia	06-C-0227	Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0227
Chronic myeloid leukemia	04-H-0112	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Peritransplant Cyclosporine on Chimerism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-H-0112
Chronic myeloid leukemia	04-H-0090	A Pilot Study of the Safety and Efficacy of Imatinib in Reducing Monocytosis or Leukocytosis in Patients with Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia, Respectively
Chronic myeloid leukemia	03-H-0192	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies Ã? Effect of Irradiated Donor Lymphocytes on Chimerism
Chronic myeloid leukemia	01-H-0162	Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Using RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched, Nonmyeloablative, Peripheral Blood Stem Cell Transplantation for H
Chronic myeloid leukemia	01-C-0125	Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0125
Chronic myeloid leukemia	99-H-0050	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-H-0050
Chronic myeloid leukemia	99-H-0046	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine
Chronic myeloid leukemia	97-H-0202	Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults
Chronic myeloid leukemia	97-H-0196	A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-H-0196
Chronic myeloid leukemia	11-C-0125	Relapsed Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation: Screening, Disease Characterization and Natural History	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0125
Chronic myeloid leukemia	09-H-0062	Collection of Blood and Bone Marrow Samples from Select Patients with CML to Measure Minimal Residual Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0062
Chronic myeloid leukemia	04-C-0102	Hematologic Malignancy Biology Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0102
Chronic myelomonocytic leukemia	04-H-0090	A Pilot Study of the Safety and Efficacy of Imatinib in Reducing Monocytosis or Leukocytosis in Patients with Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia, Respectively
Chronic myelomonocytic leukemia	01-H-0162	Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Using RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched, Nonmyeloablative, Peripheral Blood Stem Cell Transplantation for H
Chronic recurrent multifocal osteomyelitis	03-AR-0173	Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CRMO, StillÕs Disease, BehcetÕs Disease, and other Undifferentiated Autoinflammatory Diseases)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-AR-0173
Classic Kaposi sarcoma	09-C-0130	Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab Followed by Bevacizumab Monotherapy in Adults with Advanced KaposiÕs Sarcoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0130
Classic Kaposi sarcoma	06-C-0083	Phase I and Pharmacokinetic Study of BAY 43-9006 (Sorafenib) in Patients with Kaposi's Sarcoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0083
Classic Kaposi sarcoma	03-C-0110	Phase II Study of Intravenous Recombinant Humanized Anti-Vascular Endothelial Cell Growth Factor Antibody (Bevacizumab) in Classical (HIV-Negative) and in AIDS-Associated Kaposi's Sarcoma
Classic Kaposi sarcoma	88-I-0172	A Phase III Study with Long-Term Follow-Up of Zidovudine Versus Zidovudine and Alpha-Interferon Versus Alpha-Interferon in Patients with Early HIV Infection	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1988-I-0172
Classic Kaposi sarcoma	04-C-0275	Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease with Laboratory and Clinical Correlates of Disease Activity	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0275
Classic Kaposi sarcoma	01-C-0158	Protocol to Assess Vascularity in Kaposi's Sarcoma Lesions Utilizing Non-Invasive Imaging Techniques	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0158
Classic Kaposi sarcoma	01-C-0038	Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0038
Classic Kaposi sarcoma	00-C-0193	A Study of the Effects of Potent Anti-HIV Therapy on Parameters Hypothesized to Be Related to the Pathogenesis of Kaposi's Sarcoma (KS) in HIV-Infected Individuals	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-C-0193
Classic Kaposi sarcoma	97-C-0028	Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-C-0028
Clostridium difficile	0	Shigella Sonnel O-SPC/rBRU Conjugate Vaccine
COACH syndrome	03-HG-0264	Clinical Investigations into the Kidney and Liver Disease in Autosomal Recessive Polycystic Kidney Disease/Congenital Hepatic Fibrosis and other Ciliopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-HG-0264
Coccidioidomycosis	77-I-0094	Study of Patients with Parasitic Infections of the Gastrointestinal Tract	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1977-I-0094
Cold agglutinin disease	00-I-0143	Chemokine System Polymorphisms and Risk of Atherosclerosis (CAD)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-I-0143
Coloboma of optic nerve	06-EI-0230	Family Studies of Uveal Coloboma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-EI-0230
Common variable immunodeficiency	09-I-0172	Natural History of Bronchiectasis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-I-0172
Common variable immunodeficiency	09-I-0133	Establishing Fibroblast-derived Cell Lines from Skin Biopsies of Patients with Immunodeficiency or Immunodysregulation Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-I-0133
Common variable immunodeficiency	06-I-0049	Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-I-0049
Common variable immunodeficiency	01-I-0153	The Immune Basis for the Gastrointestinal Complications of Common Variable Immunodeficiency	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0153
Common variable immunodeficiency	00-HG-0209	Molecular and Clinical Studies of Primary Immunodeficiency Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-HG-0209
Common variable immunodeficiency	89-I-0158	Studies of Immune Regulation in Patients with Common Variable Immunodeficiency and Related Humoral Immunodeficiency Syndromes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-I-0158
Congenital adrenal hyperplasia	96-CH-0033	An Open, Randomized, Long-Term Clinical Trial of Flutamide, Testolactone, and Reduced Hydrocortisone Dose vs. Conventional Treatment of Children with Congenital Adrenal Hyperplasia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1996-CH-0033
Congenital adrenal hyperplasia	11-CH-0119	Adrenal Hyperplasia Among Young Women with Polycystic Ovarian Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-CH-0119
Congenital adrenal hyperplasia	01-M-0152	Adolescence, Puberty, Hormones, and Emotion Regulation: An fMRI Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-M-0152
Congenital adrenal hyperplasia	01-CH-0096	Catecholamine Reserve and Exercise Tolerance in Subjects with Congenital Adrenal Hyperplasia and Healthy Controls
Congenital adrenal hyperplasia	89-M-0006	Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Controls	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-M-0006
Congenital adrenal hyperplasia	06-CH-0011	Natural History Study of Patients with Excess Androgen	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-CH-0011
Congenital deafness	05-EI-0096	Natural History and Genetic Studies of Usher Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-EI-0096
Congenital hemolytic anemia	03-H-0170	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Severe Congenital Anemias Including Sickle Cell Disease, Thalassemia, and Diamond Blackfan Anemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-H-0170
Congenital hepatic fibrosis	03-HG-0264	Clinical Investigations into the Kidney and Liver Disease in Autosomal Recessive Polycystic Kidney Disease/Congenital Hepatic Fibrosis and other Ciliopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-HG-0264
Conversion disorder	07-N-0190	Neurobiological Studies of Psychogenic Movement Disorders and Non-Epileptic Seizures	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-N-0190
Corneal dystrophy	04-EI-0008	Clinical and Molecular Studies in Families with Corneal Dystrophy or Other Inherited Corneal Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-EI-0008
Cowden's disease	08-C-0151	A Pilot Study of Sirolimus (Rapamycin, Rapammune[Registered Trademark]) in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0151
Craniopharyngioma	97-CH-0076	A Clinical and Genetic Investigation of Pituitary Tumors and Related Hypothalmic Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-CH-0076
Craniosynostosis	05-HG-0131	Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-HG-0131
Cryoglobulinemia	02-I-0096	Rituximab (Anti-CD20) for the Treatment of Hepatitis C Associated Cryoglobulinemic Vasculitis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-I-0096
Cryptococcosis	93-I-0106	Cryptococcosis in Previously Normal Adults	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1993-I-0106
Cryptosporidiosis	77-I-0094	Study of Patients with Parasitic Infections of the Gastrointestinal Tract	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1977-I-0094
Cushing's syndrome	07-CH-0008	Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-CH-0008
Cushing's syndrome	02-CH-0309	The Diagnostic Performance of Screening Tests for the Diagnosis of Cushing's Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-CH-0309
Cushing's syndrome	01-M-0152	Adolescence, Puberty, Hormones, and Emotion Regulation: An fMRI Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-M-0152
Cushing's syndrome	00-CH-0160	Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-CH-0160
Cushing's syndrome	99-CH-0055	New Imaging Modalities in the Evaluation of Patients with Ectopic Cushing's Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-CH-0055
Cushing's syndrome	95-CH-0104	Internal Jugular Vein Sampling for ACTH Levels for the Differential Diagnosis of Cushing Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-CH-0104
Cushing's syndrome	95-CH-0059	Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-CH-0059
Cushing's syndrome	97-CH-0076	A Clinical and Genetic Investigation of Pituitary Tumors and Related Hypothalmic Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-CH-0076
Cutaneous mastocytosis	03-I-0041	Determining the Pathogenesis of Systemic Pediatric-Onset Mastocytosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-I-0041
Cutaneous mastocytosis	02-I-0277	Regulation of the Proliferation and Survival of Normal and Neoplastic Human Mast Cells	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-I-0277
Cutaneous T-cell lymphoma	07-C-0133	Phase I Study of Topical Romidepsin (Depsipeptide) in Early Stage Cutaneous T-Cell Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0133
Cutaneous T-cell lymphoma	04-C-0142	A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Cutaneous T-Cell Lymphomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0142
Cutaneous T-cell lymphoma	04-C-0031	Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease
Cutaneous T-cell lymphoma	02-H-0250	A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning with Campath-1H	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-H-0250
Cutaneous T-cell lymphoma	01-C-0049	Phase II Trial of Depsipeptide in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0049
Cystic fibrosis	09-I-0172	Natural History of Bronchiectasis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-I-0172
Cystic fibrosis	06-I-0217	Genetic Disorders of Mucociliary Clearance	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-I-0217
Cystic fibrosis	01-I-0202	Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0202
Cystic fibrosis	01-H-0198	Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-H-0198
Cystic fibrosis	98-H-0062	Role of Exotoxins in the Pathogenesis of Pseudomonas Aeruginosa	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1998-H-0062
Cystic fibrosis	96-H-0100	Role of Genetic Factors in the Pathogenesis of Lung Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1996-H-0100
Cystic fibrosis	87-DK-0029	Diagnosis and Treatment of Patients with Cystic Fibrosis and Other Disorders of the Respiratory System and Pancreas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1987-DK-0029
Cystic fibrosis	11-I-0046	Cross-Sectional Characterization of Idiopathic Bronchiectasis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-I-0046
Cystic fibrosis	97-H-0022	Bronchoscopy in Patients with Pulmonary Diseases and Research Volunteers	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-H-0022
Cysticercosis	07-M-0209	PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Neurocysticercosis Using [F-18]FBR	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-M-0209
Cysticercosis	07-M-0208	PET Imaging of Peripheral Benzodiazepine Receptors in Patients with Neurocysticercosis Using [C-11]PBR28	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-M-0208
Cysticercosis	99-I-0149	Analysis of the Occurrence of Perilesional Edema and Seizures in Patients with Inactive Cysticercosis
Cysticercosis	85-I-0127	Treatment of Cysticercosis including Neurocysticercosis with Praziquantel, Albendazole and other Novel Treatment Modalities	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1985-I-0127
Cystinosis	86-EI-0062	Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1986-EI-0062
Cystinosis	78-HG-0093	Natural History Study of the Use of Cysteamine in the Treatment of Cystinosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1978-HG-0093
Cystinosis	04-DK-0057	Renal Transplantation in Recipients with Nephropathic Cystinosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-DK-0057
Dentatorubral pallidoluysian atrophy	04-C-0031	Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease
Dermatomyositis	07-E-0012	Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
Dermatomyositis	02-AR-0156	A Randomized, Double-Blind, Placebo-Controlled Trial of Infliximab In Patients With Dermatomyositis and Polymyositis
Dermatomyositis	03-E-0099	Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-E-0099
Dermatomyositis	94-E-0165	Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-E-0165
Dermatomyositis	91-AR-0196	Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1991-AR-0196
Desmoid tumor	11-C-0061	Phase I Trial of Z-Endoxifen in Adults with Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or other Hormone Receptor-Positive Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0061
Desmoplastic small round cell tumor	11-C-0073	A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation from Related or Matched Unrelated Donors in Pediatric Patients with Solid Tumors and Leukemias	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0073
Desmoplastic small round cell tumor	10-C-0120	A Phase I Study of Pazopanib as a Single Agent for Children with Relapsed or Refractory Solid Tumors, including CNS Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0120
Desmoplastic small round cell tumor	08-C-0080	SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0080
Desmoplastic small round cell tumor	02-C-0259	Pilot Study of Allogeneic/Syngeneic Blood Stem Cell Transplantation in Patients with High-Risk and Recurrent Pediatric Sarcomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0259
Desmosterolosis	02-CH-0311	Investigations into Inborn Errors of Cholesterol Synthesis and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-CH-0311
Diamond-Blackfan anemia	03-H-0170	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Severe Congenital Anemias Including Sickle Cell Disease, Thalassemia, and Diamond Blackfan Anemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-H-0170
Diamond-Blackfan anemia	02-C-0052	Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0052
DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	11-C-0034	Dicer1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0034
Diffuse scleroderma	03-E-0099	Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-E-0099
Diphtheria	01-I-0226	Evaluation of Immune Response to Vaccines in Primary Immune Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0226
DIRA	03-AR-0173	Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CRMO, StillÕs Disease, BehcetÕs Disease, and other Undifferentiated Autoinflammatory Diseases)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-AR-0173
DIRA	94-HG-0105	Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-HG-0105
Dopamine beta hydroxylase deficiency	08-N-0012	L-Dihydroxyphenylserine (L-DOPS) for Norepinephrine Deficiency: Interactions with Carbidopa and Entacapone	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-N-0012
Dwarfism	92-CH-0034	Studies of Growth Deficiency and Growth Hormone Treatment in Children with Osteogenesis Imperfecta Types III and IV	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1992-CH-0034
Dwarfism	97-CH-0064	Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-CH-0064
Dyskinesia, drug induced	85-N-0195	A Training Protocol for the use of Botulinum Toxin in the Treatment of Neurological Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1985-N-0195
Ectodermal dysplasia	06-I-0049	Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-I-0049
Eosinophilic enteropathy	10-I-0196	Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0196
Eosinophilic enteropathy	96-I-0129	Evaluation and Long Term Follow-up of Patients with Allergic and Inflammatory Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1996-I-0129
Ependymoma	09-C-0243	A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-Ribose) Polymerase and Temozolomide in Children with Recurrent/Refractory CNS Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0243
Ependymoma	05-C-0132	A Phase I Trial of CC-5013 (Lenalidomide) in Pediatric Patients with Recurrent or Refractory Primary CNS Tumors
Ependymoma	10-C-0105	A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children with Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0105
Ependymoma	08-N-0044	A Prospective Natural History Study of Patients with Neurofibromatosis Type 2 (NF2)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-N-0044
Esophageal cancer	11-C-0041	Epigenetically-Modified Autologous Tumor Cell Vaccines with ISCOMATRIX(TM) Adjuvant and Oral Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thoracic Sarcomas, and Malignant Pleural Mesotheliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0041
Esophageal cancer	10-C-0138	Allogeneic Tumor Cell Vaccine with Metronomic Oral Cyclophosphamide and Celecoxib as Adjuvant Therapy for Lung and Esophageal Cancers, Thymic Neoplasms, Thoracic Sarcomas, and Malignant Pleural Mesotheliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0138
Esophageal cancer	05-C-0010	Phase I Study of Sequential Depsipeptide/Flavopiridol Infusion for Malignancies Involving Lungs, Esophagus, Pleura, Thymus or Mediastinum	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-C-0010
Esophageal cancer	07-C-0111	A Pilot Study of Markers of Tumor Burden and Radiation Toxicity in the Blood, Urine, and Stool of Patients Receiving Radiotherapy for Gastrointestinal Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0111
Esophageal cancer	06-C-0014	Prospective Evaluation of Epigenetic Alterations in Patients with Thoracic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0014
Esophageal cancer	09-C-0100	A Natural History Study of Patients Receiving High Dose Rate Brachytherapy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0100
Ewing's sarcoma	11-C-0073	A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation from Related or Matched Unrelated Donors in Pediatric Patients with Solid Tumors and Leukemias	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0073
Ewing's sarcoma	10-C-0120	A Phase I Study of Pazopanib as a Single Agent for Children with Relapsed or Refractory Solid Tumors, including CNS Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0120
Ewing's sarcoma	08-C-0080	SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0080
Ewing's sarcoma	07-C-0206	A Pilot Study of Tumor Vaccination and R-hIL-7 Following Standard Multimodality Therapy in Patients with High Risk Pediatric Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0206
Ewing's sarcoma	07-C-0054	A Phase I Trial and Pharmacokinetic Study of Trabectedin (YONDELIS [R], ET-743) in Children and Adolescents with Relapsed or Refractory Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0054
Ewing's sarcoma	07-C-0040	A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) with or without Interferon Gamma in Patients with Refractory Pediatric Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0040
Ewing's sarcoma	02-C-0259	Pilot Study of Allogeneic/Syngeneic Blood Stem Cell Transplantation in Patients with High-Risk and Recurrent Pediatric Sarcomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0259
Ewing's sarcoma	01-C-0091	Phase I Trial and Pharmacokinetic Study of Tariquidar (XR9576), a P-Glycoprotein Inhibitor, in Combination with Doxorubicin, Vinorelbine or Docetaxel in Pediatric Patients with Refractory Solid Tumors Including Brain Tumors
Ewing's sarcoma	00-C-0092	A Randomized Trial of Filgrastim-SD/01 vs. Filgrastim in Newly Diagnosed Children and Young Adults with Sarcoma Treated with Dose-Intensive Chemotherapy
Ewing's sarcoma	97-C-0052	A Pilot Study of Autologous T-Cell Transplantation with Vaccine Driven Expansion of Anti-Tumor Effectors after Cytoreductive Therapy in Metastatic Pediatric Sarcomas
Ewing's sarcoma	97-C-0050	A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 with or without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas
Ewing's sarcoma	09-C-0054	A Group Wide Biology and Banking Study for Phase II Study of R1507	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0054
Ewing's sarcoma	98-C-0037	Treatment of Children with Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1998-C-0037
Fallopian tube cancer	11-C-0080	Ph II Randomized Trial of the Combination of ABT-888 with Metronomic Oral Cyclophosphamide in Refractory BRCA-Pos Ovarian, Primary Peritoneal or Ovarian High-Grade Serous Carcinoma, Fallopian Tube Cancer, Triple-Neg Breast Cancer, and Low-Grade NHL	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0080
Fallopian tube cancer	11-C-0061	Phase I Trial of Z-Endoxifen in Adults with Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or other Hormone Receptor-Positive Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0061
Fallopian tube cancer	11-C-0022	A Pharmacokinetic/Pharmacodynamic Study with a Phase I Run-In with a PARP Inhibitor (Olaparib) in Combination with Carboplatin for Refractory or Recurrent Women's Cancers	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0022
Fallopian tube cancer	10-C-0028	Phase II Study of Clinical Activity of Pegaspargase in Women with Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0028
Fallopian tube cancer	07-C-0061	Phase II Study of Clinical Activity and Proteomic Pathway Profiling of the VEGFR2 Inhibitor, Vandetanib in Women With Relapsed or Refractory Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Fallopian tube cancer	07-C-0058	A Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian, Fallopian, and Peritoneal Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0058
Fallopian tube cancer	04-C-0232	A Multi-Institutional Study of Proteomic Evaluation of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile of Relapse	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0232
Fallopian tube cancer	11-C-0033	Extended Follow-up of High Ovarian Cancer Risk Cohort from 02-C-0268 (GOG-199)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0033
Familial cold autoinflammatory syndrome	10-AR-0182	A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome (FCAS) / Muckle-Wells Syndrome (MWS) and BehcetÕs Disease (BD)
Familial cold autoinflammatory syndrome	05-AR-0014	Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects with Autoinflammatory Disease: A Therapeutic Approach to Study Pathogenesis
Familial cold autoinflammatory syndrome	94-HG-0105	Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-HG-0105
Familial Mediterranean fever	08-AR-0218	Phase II Trial of Rilonacept for Treatment of Familial Mediterranean Fever (FMF)
Familial Mediterranean fever	05-AR-0014	Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects with Autoinflammatory Disease: A Therapeutic Approach to Study Pathogenesis
Familial Mediterranean fever	94-HG-0105	Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-HG-0105
Familial renal cell carcinoma	89-C-0086	Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-C-0086
Fanconi anemia	02-C-0052	Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0052
Fanconi anemia	97-H-0130	Collection of Blood and Bone Marrow from Healthy Volunteers and Patients for Research Purposes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-H-0130
Fibrous dysplasia	98-D-0146	A Randomized, Placebo-Controlled Trial of Alendronate in the Treatment of Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1998-D-0146
Fibrous dysplasia	98-D-0145	Screening and Natural History of Patients with Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1998-D-0145
Focal dystonia	08-N-0181	Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia and Other Focal Dystonias	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-N-0181
Focal dystonia	07-N-0165	Suppression and Facilitation of the Motor Cortex by Stimulation of the Cerebellum in Patients with Dystonia and Healthy Controls	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-N-0165
Focal dystonia	06-N-0128	fMRI Studies of Task Specificity in Focal Hand Dystonia
Focal dystonia	05-N-0189	Neuropathological Basis of Spasmodic Dysphonia and Related Voice Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-N-0189
Focal dystonia	02-N-0132	In Vivo Mapping Of Structural and Biochemical Abnormalities In Patients With Primary Focal Dystonia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-N-0132
Focal dystonia	10-N-0092	Genetics of Motor Learning	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-N-0092
Focal segmental glomerulosclerosis	05-DK-0015	Retinoids for Podocyte Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-DK-0015
Focal segmental glomerulosclerosis	03-DK-0226	Pulse Dexamethasone Over 48 Weeks for Podocyte Disease
Focal segmental glomerulosclerosis	01-DK-0053	Permeability Factor in Focal Segmental Glomerulosclerosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-DK-0053
Focal segmental glomerulosclerosis	00-DK-0042	Pirfenidone in Focal Segmental Glomerulosclerosis:Phase II Study
Focal segmental glomerulosclerosis	06-DK-0020	Kidney Disease Biomarkers	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-DK-0020
Focal segmental glomerulosclerosis	94-DK-0133	Genetic Markers for Focal Segmental Glomerulosclerosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-DK-0133
Focal segmental glomerulosclerosis	94-DK-0127	Pathogenesis of Glomerulosclerosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-DK-0127
Focal segmental glomerulosclerosis	11-DK-0023	Nephrotic Diseases Study Network	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-DK-0023
Focal segmental glomerulosclerosis	10-DK-0135	Role of Donor Genetics and Recipient Genetics in Kidney Transplant Outcomes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-DK-0135
Focal segmental glomerulosclerosis	07-DK-0212	Prospective Evaluation of Albuminuria in HIV Positive Patients	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-DK-0212
Follicular lymphoma	10-C-0067	A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0067
Follicular lymphoma	09-C-0082	Assessment of the Safety and Feasibility of Administering T Cells Expressing an anti-CD19 Chimeric Antigen Receptor to Patients with B-cell Lymphoma or Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0082
Follicular lymphoma	07-C-0006	A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics and Efficacy of ABT-263 in Subjects with Relapsed or Refractory Lymphoid Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0006
Follicular lymphoma	05-C-0031	A Randomized Trial of Patient-Specific Vaccination with Conjugated Follicular Lymphoma-Derived Idiotype with Local GM-CSF in First Complete Remission	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-C-0031
Follicular lymphoma	93-C-0133	Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Patients with Aggressive Non-Hodgkin's Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1993-C-0133
Fragile X syndrome	06-M-0214	PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects with Fragile X Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-M-0214
Fragile X syndrome	10-CH-0144	The Natural History of Reproductive and Overall Health in Women with a Pre-Mutation in the FMR1 Gene: Creation of a Patient Registry	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-CH-0144
Friedreich ataxia	05-N-0245	A Six Month Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Determine the Safety and Efficacy of Idebenone Administered to Patients with Friedreich's Ataxia
Frontotemporal dementia	08-N-0045	Investigation of the Dopamine System in Frontotemporal Dementia
Frontotemporal dementia	81-N-0010	Regional Cerebral Utilization of Glucose in Patients with a Diagnosis of Frontal Lobe Dementia, Atypical Parkinsonian Disorder, and Other Basal Ganglia Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1981-N-0010
Frontotemporal dementia	08-M-0124	Measurement of P-Glycoprotein Function in Alzheimer Disease, Parkinson Disease, and Frontotemporal Dementia Using Positron Emission Tomography
Frontotemporal dementia	08-M-0066	PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Neurological Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-M-0066
Gaucher disease	06-HG-0055	Functional Imaging in Subjects with Glucocerebrosidase Mutations	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-HG-0055
Gaucher disease	02-HG-0107	Investigation of Neurodegeneration in the Glycosphingolipid Storage Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-HG-0107
Gaucher disease	86-HG-0096	Studies of Genetic Heterogeneity in Patients with Lysosomal Storage Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1986-HG-0096
Geographic tongue	06-I-0207	Investigation of Southern Tick-Associated Rash Illness (STARI)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-I-0207
Geographic tongue	05-I-0219	Microarray Analysis of Erythema Migrans Lesions	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-I-0219
Germinoma	02-C-0178	Multidisciplinary Etiologic Study of Familial Testicular Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0178
Glioblastoma	11-C-0141	A Phase 1 Study of MK-2206, an AKT Inhibitor, in Pediatric Patients with Recurrent or Refractory Solid Tumors or Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0141
Glioblastoma	11-C-0122	Phase I Trial of AZD8055, An Oral MTOR Kinase Inhibitor, for Adults with Recurrent Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0122
Glioblastoma	09-C-0222	A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination with Carboplatin versus Carboplatin Alone Followed by Vandetanib Alone in Adults with Recurrent High-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0222
Glioblastoma	09-C-0080	A Phase 2, Open-label, Proof-of-Concept Study to Assess the Ability to Detect Tumours and Angiogenesis via the Expression of Alpha v Beta 3 Integrin Receptors by (18F)AH-111585 PET Imaging	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0080
Glioblastoma	08-C-0168	A Phase II Trial of Sunitinib in the Treatment of Recurrent Malignant Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0168
Glioblastoma	08-C-0101	A Phase 2 Trial of Tandutinib in Combination with Bevacizumab for Patients with Recurrent High-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0101
Glioblastoma	08-C-0015	A Phase II Trial of Enzastaurin (LY317615) in Combination with Bevacizumab in Adults with Recurrent Malignant Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0015
Glioblastoma	06-C-0112	A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination with Temodar and Radiation Therapy in Patients with High Grade Gliomas: Multi-Institutional Trial	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0112
Glioblastoma	05-C-0134	A Biomarker and Phase II Study of GW572016 in Recurrent Malignant Glioma
Glioblastoma	03-C-0002	A Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron(TM)) and Thalidomide in Adults with Recurrent High-Grade Gliomas
Glioblastoma	11-C-0081	(11C)N-Desmethyl-Loperamide as a Marker of P-Glycoprotein Function in Patients with Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0081
Glioblastoma	10-C-0105	A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children with Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0105
Glioblastoma	06-N-0085	Two-Compartment Model of Diffusion Tensor Magnetic Resonance Imaging (DT-MRI) for the Diagnosis of Glioma Tumor Recurrence versus Radiation Necrosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-N-0085
Glioblastoma	04-C-0200	Urinary and Serum VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0200
Glioblastoma	01-C-0070	Evaluation of the Natural History of Patients with Tumors of the Central Nervous System	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0070
Glioblastoma	11-C-0036	A Pilot Study of Inpatient Hospice with Procurement of Brain Tumor Tissue on Expiration for Research Purposes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0036
Glioblastoma	03-N-0164	Evaluation and Treatment of Neurosurgical Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-N-0164
Glioma	11-C-0122	Phase I Trial of AZD8055, An Oral MTOR Kinase Inhibitor, for Adults with Recurrent Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0122
Glioma	11-C-0053	A Phase I Study of Temirolimus in Combination with Irinotecan and Temozolomide in Children, Adolescents, and Young Adults with Relapsed or Refractory Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0053
Glioma	11-C-0003	A Phase I Study of Vorinostat and Temozolomide in Children with Relapsed or Refractory Primary Brain or Spinal Cord Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0003
Glioma	10-C-0219	A Phase I Trial of Lenalidomide and Radiotherapy in Children with Diffuse Intrinsic Pontine Gliomas and High-grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0219
Glioma	10-C-0190	A Phase II Trial of Capecitabine Rapidly Disintegrating Tablets and Concomitant Radiation Therapy in Children with Newly Diagnosed Brainstem Gliomas
Glioma	10-C-0175	A Phase I Study of IMC-A12 (Anti-Insulin-like Growth Factor-I Receptor Monoclonal Antibody) in Combination with CCI-779 (Temsirolimus) in Pediatric Patients with Recurrent or Refractory Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0175
Glioma	09-N-0117	An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients with Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-N-0117
Glioma	09-C-0243	A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-Ribose) Polymerase and Temozolomide in Children with Recurrent/Refractory CNS Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0243
Glioma	09-C-0222	A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination with Carboplatin versus Carboplatin Alone Followed by Vandetanib Alone in Adults with Recurrent High-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0222
Glioma	09-C-0080	A Phase 2, Open-label, Proof-of-Concept Study to Assess the Ability to Detect Tumours and Angiogenesis via the Expression of Alpha v Beta 3 Integrin Receptors by (18F)AH-111585 PET Imaging	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0080
Glioma	08-C-0168	A Phase II Trial of Sunitinib in the Treatment of Recurrent Malignant Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0168
Glioma	08-C-0101	A Phase 2 Trial of Tandutinib in Combination with Bevacizumab for Patients with Recurrent High-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0101
Glioma	08-C-0015	A Phase II Trial of Enzastaurin (LY317615) in Combination with Bevacizumab in Adults with Recurrent Malignant Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0015
Glioma	07-C-0053	A Phase I Trial of Enzastaurin (LY317615) in Combination with Carboplatin in Adults with Recurrent Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0053
Glioma	06-C-0250	A Phase II Trial of Bevacizumab and Irinotecan for Patients with Recurrent High-Grade Gliomas Immediately Following Tumor Progression after Treatment w/Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)
Glioma	06-C-0112	A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination with Temodar and Radiation Therapy in Patients with High Grade Gliomas: Multi-Institutional Trial	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0112
Glioma	06-C-0064	A Phase II Trial of Bevacizumab for Patients with Recurrent High-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0064
Glioma	06-C-0063	A Phase I/II Trial of ZD6474 for Patients with Recurrent High-Grade and Progressive Low-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0063
Glioma	05-C-0137	A Phase II Trial of Tamoxifen and Bortezomib in Patients with Recurrent High-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-C-0137
Glioma	05-C-0136	A Phase I Trial of Enzastaurin (LY317615) in Patients with Recurrent Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-C-0136
Glioma	05-C-0134	A Biomarker and Phase II Study of GW572016 in Recurrent Malignant Glioma
Glioma	05-C-0132	A Phase I Trial of CC-5013 (Lenalidomide) in Pediatric Patients with Recurrent or Refractory Primary CNS Tumors
Glioma	03-C-0002	A Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron(TM)) and Thalidomide in Adults with Recurrent High-Grade Gliomas
Glioma	02-C-0193	A Phase II Study of Pegylated Interferon Alfa-2b (Peg-Intron (TM)) in Children with Diffuse Pontine Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0193
Glioma	97-C-0093	A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors
Glioma	11-C-0081	(11C)N-Desmethyl-Loperamide as a Marker of P-Glycoprotein Function in Patients with Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0081
Glioma	10-C-0105	A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children with Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0105
Glioma	06-N-0085	Two-Compartment Model of Diffusion Tensor Magnetic Resonance Imaging (DT-MRI) for the Diagnosis of Glioma Tumor Recurrence versus Radiation Necrosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-N-0085
Glioma	02-C-0140	A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas: The Glioma Molecular Diagnostic Initiative	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0140
Glioma	01-C-0070	Evaluation of the Natural History of Patients with Tumors of the Central Nervous System	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0070
Glioma	11-C-0036	A Pilot Study of Inpatient Hospice with Procurement of Brain Tumor Tissue on Expiration for Research Purposes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0036
Gliosarcoma	09-C-0222	A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination with Carboplatin versus Carboplatin Alone Followed by Vandetanib Alone in Adults with Recurrent High-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0222
Gliosarcoma	08-C-0101	A Phase 2 Trial of Tandutinib in Combination with Bevacizumab for Patients with Recurrent High-Grade Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0101
Gliosarcoma	08-C-0015	A Phase II Trial of Enzastaurin (LY317615) in Combination with Bevacizumab in Adults with Recurrent Malignant Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0015
Gliosarcoma	05-C-0134	A Biomarker and Phase II Study of GW572016 in Recurrent Malignant Glioma
Gliosarcoma	11-C-0036	A Pilot Study of Inpatient Hospice with Procurement of Brain Tumor Tissue on Expiration for Research Purposes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0036
Glomerulonephritis	03-DK-0071	Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy
Glomerulonephritis	92-DK-0156	Studies of Immunologically-Mediated Kidney Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1992-DK-0156
Glomerulonephritis	11-DK-0023	Nephrotic Diseases Study Network	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-DK-0023
Glomerulonephritis	06-DK-0199	Analysis of Stored Identified Data and Kidney Biopsy Specimens from Patients Enrolled in Protocol 86-DK-0204	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-DK-0199
Granulocytopenia	04-C-0089	Phase I Open-Label Single-Dose Study of Humanized Mik-Beta-1 Monoclonal Antibody Directed Toward the IL-2R/IL-15R-Beta Subunit (CD122) in T Cell Large Granular Lymphocytic Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0089
Gray platelet syndrome	04-HG-0226	Investigations of Megakaryocytes from Patients with Abnormal Platelet Vesicles	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-HG-0226
Gray platelet syndrome	03-HG-0313	Genetic Analysis of Gray Platelet Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-HG-0313
Greenberg dysplasia	02-CH-0311	Investigations into Inborn Errors of Cholesterol Synthesis and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-CH-0311
Greig cephalopolysyndactyly syndrome	94-HG-0193	Genetic and Clinical Studies of Congenital Anomaly Syndromes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-HG-0193
Growth hormone deficiency	11-CH-0004	Free Fatty Acids, Body Weight, and Growth Hormone Secretion in Children	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-CH-0004
Hairy cell leukemia	10-C-0025	Randomized Phase II Trial of Rituximab with Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0025
Hairy cell leukemia	09-C-0005	Randomized Trial of Cladribine (CdA) with Simultaneous or Delayed Rituximab to Eliminate Hairy Cell Leukemia Minimal Residual Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0005
Hairy cell leukemia	07-C-0130	A Phase 1, Multicenter, Dose-Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Hairy Cell Leukemia (HCL)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0130
Hairy cell leukemia	06-C-0150	A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for CD25 Positive Hairy Cell Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0150
Hairy cell leukemia	04-C-0121	A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Chronic Lymphocytic Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0121
Hairy cell leukemia	10-C-0066	Collection of Human Samples to Study Hairy Cell and Other Leukemias and to Develop Recombinant Immunotoxins for Cancer Treatment	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0066
Helminthiasis	00-I-0099	Langherhans' Cell Function and Inflammatory Responses in Skin of Normal Volunteers and Patients with Helminth Infections Using the Suction Blister Technique	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-I-0099
Helminthiasis	94-I-0079	Eosinophil Activation and Function in Parasitic Infections and Other Conditions with Increased Tissue or Peripheral Blood Eosinophilia in Humans	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-I-0079
Helminthiasis	88-I-0083	Host Response to Infection and Treatment in the Filarial Diseases of Humans	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1988-I-0083
Hemangioblastoma	00-N-0140	A Prospective Natural History Study of VHL Patients with CNS Hemangioblastomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-N-0140
Hemangioblastoma	89-C-0086	Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-C-0086
Hemoglobin SC disease	04-H-0161	Studies of the Natural History of Sickle Cell Disease and Other Hemolytic Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-H-0161
Hemoglobinuria	97-H-0117	A Randomized Trial of Antithymocyte Globulin and Cyclosporine versus Cyclophosphamide and Cyclosporine in the Treatment of Severe Aplastic Anemia
Hemolytic uremic syndrome	06-C-0150	A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for CD25 Positive Hairy Cell Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0150
Hepatic fibrosis	00-DK-0186	The Hep C Antiviral Long-Term Tx Against Cirrhosis (HALT-C) Trial: A Randomized Controlled Trial to Evaluate the Safety & Efficacy of Long-Term Peginterferon Alpha2A for Tx of Chronic Hep C in Patients Who Failed to Respond to Previous Interferon Therapy
Hepatic fibrosis	06-I-0153	A Pilot Study of Hepatic Fibrosis in HIV/AIDS Patients with Chronically Elevated Transaminases on Antiretroviral Therapy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-I-0153
Hepatic fibrosis	03-HG-0264	Clinical Investigations into the Kidney and Liver Disease in Autosomal Recessive Polycystic Kidney Disease/Congenital Hepatic Fibrosis and other Ciliopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-HG-0264
Hepatocellular carcinoma, adult	11-C-0102	A Phase I/II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma (HCC)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0102
Hepatocellular carcinoma, adult	04-C-0273	A Phase II Study of Hepatic Arterial Infusion of Melphalan with Venous Filtration via Peripheral Hepatic Perfusion (PHP) for Unresectable Primary and Metastatic Cancers of the Liver	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0273
Hepatocellular carcinoma, adult	09-DK-0067	Long-Term Follow-Up of HALT-C Sustained Virologic Responders
Hereditary ataxia	08-N-0153	The Role of Autoimmunity in Neurologic Complications of Celiac Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-N-0153
Hereditary ataxia	01-N-0206	Phenotype/Genotype Correlations in Movement Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-N-0206
Hereditary hearing disorder	01-DC-0229	Genetic Analysis of Hereditary Disorders of Hearing and Balance	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-DC-0229
Hermansky-Pudlak syndrome	07-HG-0132	Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-HG-0132
Hermansky-Pudlak syndrome	97-HG-0085	Therapeutic Clinical Trial of Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-HG-0085
Hermansky-Pudlak syndrome	04-HG-0226	Investigations of Megakaryocytes from Patients with Abnormal Platelet Vesicles	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-HG-0226
Hermansky-Pudlak syndrome	95-HG-0193	Clinical and Basic Investigations into Hermansky-Pudlak Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-HG-0193
Hermansky-Pudlak syndrome	82-I-0183	Study of the Immune Regulation of Idiopathic Inflammatory Bowel Diseases: Crohn's Disease, Ulcerative Colitis, and Other Inflammatory Conditions of the Gut	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1982-I-0183
Hodgkin lymphoma	10-C-0056	A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0056
Hodgkin lymphoma	10-C-0050	A Randomized Phase II Study of Rituximab with ABVD Versus Standard ABVD for Subjects with Advanced-Stage Classical Hodgkin Lymphoma with Poor Risk Features (IPS score >2)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0050
Hodgkin lymphoma	10-C-0011	Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0011
Hodgkin lymphoma	09-C-0224	Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0224
Hodgkin lymphoma	07-C-0195	Pilot Trial of Targeted Immune-Depleting Chemo & Reduced-Intensity Allo Hematopoietic SCT Using 8/8 & 7/8 HLA-Matched Unrelated Donors and Utilizing 2 GVHD Prophy Regimens for the Tx of Leukemias, Lymphomas, & Pre-Malignant Blood Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0195
Hodgkin lymphoma	01-H-0162	Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Using RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched, Nonmyeloablative, Peripheral Blood Stem Cell Transplantation for H
Hodgkin lymphoma	01-C-0125	Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0125
Hodgkin lymphoma	99-H-0050	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-H-0050
Holoprosencephaly	04-HG-0093	Clinical and Genetic Studies on Holoprosencephaly	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-HG-0093
Holoprosencephaly	98-HG-0249	Genetic Analysis of Brain Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1998-HG-0249
HTLV-1 associated myelopathy/tropical spastic paraparesis	04-N-0071	Phase I/II Study of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Using the Humanized MiK-Beta-1 Monoclonal Antibody Directed Toward the IL-2/IL-15R-Beta Subunit (CD122) that Blocks IL-15 Action	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-N-0071
HTLV-1 associated myelopathy/tropical spastic paraparesis	98-N-0047	Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1998-N-0047
Human T-cell leukemia virus type 1	09-C-0025	Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0025
Human T-cell leukemia virus type 1	04-N-0071	Phase I/II Study of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Using the Humanized MiK-Beta-1 Monoclonal Antibody Directed Toward the IL-2/IL-15R-Beta Subunit (CD122) that Blocks IL-15 Action	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-N-0071
Human T-cell leukemia virus type 1	03-C-0194	Phase II Study of the Efficacy and Toxicity of Campath-1H in the Therapy of Adult T-Cell Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-C-0194
Human T-cell leukemia virus type 1	00-C-0030	A Phase I/II Study of the Efficacy and Toxicity of Humanized Anti-Tac (Zenapaxª) in the Therapy of Tac-Expressing Adult T-Cell Leukemia
Human T-cell leukemia virus type 1	01-C-0038	Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0038
Human T-cell leukemia virus type 1	98-N-0047	Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1998-N-0047
Human T-cell leukemia virus type 1	97-C-0143	Collection of Blood, Bone Marrow and Tissue Samples for the Investigation of the Human Immune Response, Lymphoma Biology and HTLV-1 Infection	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-C-0143
Hyperandrogenism	11-CH-0119	Adrenal Hyperplasia Among Young Women with Polycystic Ovarian Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-CH-0119
Hyperandrogenism	06-CH-0011	Natural History Study of Patients with Excess Androgen	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-CH-0011
Hypereosinophilic syndromes	07-I-0039	A Compassionate Use Open-Label Study of Anti IL-5 (Mepolizumab) Treatment in Subjects with Hypereosinophilic Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-I-0039
Hypereosinophilic syndromes	02-I-0286	A Pilot Study of the Safety and Efficacy of Imatinib Mesylate in Reducing Eosinophilia in Patients with the Myeloproliferative Variant Hypereosinophilic Syndrome (HES) or Non-Myeloproliferative HES Refractory to Standard Therapy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-I-0286
Hypoaldosteronism	91-CH-0127	Ovarian Follicle Function in Patients with Premature Ovarian Failure	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1991-CH-0127
Hypocalciuric hypercalcemia, familial, type 1	93-DK-0127	Family Studies in Metabolic Diseases and Mineral Metabolism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1993-DK-0127
Hypolipoproteinemia	79-H-0100	Teaching Protocol for the Evaluation of Plasma Lipoproteins	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1979-H-0100
Hypomelanotic disorder	09-HG-0035	Clinical, Cellular, and Molecular Investigations into Oculocutaneous Albinism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-HG-0035
Hypoparathyroidism	08-CH-0203	A Pilot Study to Assess the Feasibility of PTH 1-34 Therapy via Pump in the Management of Chronic Hypoparathyroidism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-CH-0203
Hypoparathyroidism	07-D-0016	Effects of PTH Replacement on Bone in Hypoparathyroidism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-D-0016
Hypoparathyroidism	92-CH-0011	Treatment of Hypoparathyroidism with Synthetic Human Parathyroid Hormone 1-34	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1992-CH-0011
Hypoparathyroidism	91-DK-0085	Studies of Hyperparathyroidism and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1991-DK-0085
Hypopituitarism	07-CH-0192	Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-CH-0192
Ichthyosis vulgaris	08-HG-0059	Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-HG-0059
Idiopathic myopathy	07-E-0012	Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
Idiopathic myopathy	06-N-0113	Phase II Clinical Trial to Examine the Efficacy and Safety of Dutasteride in Patients with Kennedy's Disease (Spinal and Bulbar Muscular Atrophy)
Idiopathic myopathy	11-E-0072	Environmental Risk Factors for the Anti-Synthetase Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-E-0072
Idiopathic myopathy	03-E-0099	Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-E-0099
Idiopathic myopathy	02-AR-0131	Collection Of Blood Components Using Apheresis From Patients With Rheumatic Diseases And Healthy Volunteers	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-AR-0131
Idiopathic myopathy	94-E-0165	Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-E-0165
Idiopathic myopathy	91-AR-0196	Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1991-AR-0196
Idiopathic pulmonary fibrosis	99-HG-0056	Pulmonary Fibrosis Associated with Rheumatoid Arthritis: Definition of the Natural History of Disease
Idiopathic pulmonary hypertension	08-CC-0133	The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients with Pulmonary Hypertension: Initial Studies for Establishing Guidelines	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-CC-0133
Idiopathic pulmonary hypertension	05-CC-0041	Endothelial Cell Dysfunction in Pulmonary Arterial Hypertension: Biomarkers, Mechanisms of Disease and Novel Therapeutic Targets
Immune thrombocytopenia	97-C-0178	Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-C-0178
Inflammatory breast cancer	01-C-0173	A Pilot Study to Evaluate Angiogenesis after Treatment with Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) in Previously Untreated Patients with Inflammatory Breast Cancer or Locally Advanced Breast Cancer
Inflammatory breast cancer	96-C-0104	A Multi-Center Study of Paclitaxel/Cyclophosphamide and High Dose Melphalan/Etoposide with Autologous Progenitor Cell Transplantation for the Treatment of Inflammatory Breast Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1996-C-0104
Insulinoma	91-DK-0066	Fasting Hypoglycemia: Diagnosis and Treatment	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1991-DK-0066
Isaac's syndrome	01-N-0145	Screening: Neurologic Disorders with Muscle Stiffness	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-N-0145
Joubert syndrome	03-HG-0264	Clinical Investigations into the Kidney and Liver Disease in Autosomal Recessive Polycystic Kidney Disease/Congenital Hepatic Fibrosis and other Ciliopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-HG-0264
Juvenile dermatomyositis	07-E-0012	Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
Juvenile dermatomyositis	94-E-0165	Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-E-0165
Juvenile myelomonocytic leukemia	06-C-0233	A Phase I/II Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0233
Juvenile myelomonocytic leukemia	01-C-0125	Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0125
Juvenile myelomonocytic leukemia	04-C-0102	Hematologic Malignancy Biology Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0102
Juvenile retinoschisis	03-EI-0033	X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-EI-0033
Kartagener syndrome	08-I-0067	Ciliary Dysfunction as an Underlying Etiology Linking Primary Ciliary Dyskinesia with Heterotaxy and Complex Congenital Heart Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-I-0067
Keratomalacia	05-EI-0096	Natural History and Genetic Studies of Usher Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-EI-0096
Kidney cancer	11-C-0062	Phase I/II Study of Metastatic Cancer that Expresses MAGE-A3/12 Using Lymphodepleting Conditioning Followed by Infusion of Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0062
Kidney cancer	10-C-0145	Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0145
Kidney cancer	10-C-0114	A Phase II Study of Bevacizumab and Erlotinib in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0114
Kidney cancer	10-C-0078	A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0078
Kidney cancer	10-C-0021	A Phase I Study of Intravenous Recombinant Human IL-15(rhIL-15) in Adults with Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0021
Kidney cancer	09-C-0138	A Broad Multi-Histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-Small Cell Lung, Head and Neck, Hepatocelluar and Renal Cell Carcinomas and Pheochromocytoma and Thyroid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0138
Kidney cancer	09-C-0111	A Phase 1, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612, NSC 281612) in Advanced Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0111
Kidney cancer	09-C-0092	Phase 1/2 Study of Metastatic Renal Cancer using T-Cells Transduced with a T-Cell Receptor which Recognizes TRAIL Bound to the DR4 Receptor	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0092
Kidney cancer	09-C-0080	A Phase 2, Open-label, Proof-of-Concept Study to Assess the Ability to Detect Tumours and Angiogenesis via the Expression of Alpha v Beta 3 Integrin Receptors by (18F)AH-111585 PET Imaging	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0080
Kidney cancer	09-C-0072	Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas with Botulinum Toxin	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0072
Kidney cancer	08-H-0186	Safety and the Anti-Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NKÃ?TRAIL Cytotoxicity with Bortezomib	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-H-0186
Kidney cancer	08-C-0121	Phase II Study of Metastatic Cancer that Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 TCR-Gene Engineered Lymphocytes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0121
Kidney cancer	08-C-0088	Low Intensity Allogeneic Hematopoietic Stem Cell Transplantation Therapy of Metastatic Renal Cell Carcinoma Using Early and Multiple Donor Lymphocyte Infusions Consisting of Sirolimus-Generated Donor Th2 Cells	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0088
Kidney cancer	07-C-0121	A Phase 2 Study of the C-Met RTK Inhibitor Foretinib (Formerly GSK 1363089) in Subjects with Papillary Renal-Cell Carcinoma (PRC)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0121
Kidney cancer	06-C-0115	Studies on the Mechanism of Action of High-Dose IL-2 in Metastatic Melanoma and Renal Cell Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0115
Kidney cancer	04-C-0238	A Phase II Study of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Von Hippel Lindau Disease and Renal Tumors
Kidney cancer	03-C-0284	A Clinical Trial of the P-Glycoprotein Antagonist, Tariquidar (XR9576), in Combination With Docetaxel in Patients With Lung, Ovarian, Renal and Cervical Cancer: Analysis of the Interaction Between Tariquidar and Docetaxel
Kidney cancer	02-C-0130	A Phase II Clinical Trial of BMS-247550 (NSC 710428), an Epothilone B Analog, in Renal Cell Carcinoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0130
Kidney cancer	00-C-0121	A Phase I Investigation of IL-12/Pulse IL-2 in Adults with Advanced Solid Tumors
Kidney cancer	97-H-0196	A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-H-0196
Kidney cancer	03-C-0066	Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-C-0066
Kidney cancer	02-C-0159	The Birt Hogg-Dube Syndrome: Identification of the Disease Gene and Characterization of the Predisposition of Renal Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0159
Kidney cancer	99-C-0053	Von Hippel-Lindau (VHL) Disease Genetic Epidemiology Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-C-0053
Kidney cancer	97-C-0147	Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-C-0147
Kidney cancer	10-C-0086	Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0086
Klinefelter syndrome	89-M-0006	Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Controls	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-M-0006
Large granular lymphocyte leukemia	06-H-0190	Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders with Alemtuzumab (Campath)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-H-0190
Large granular lymphocyte leukemia	04-C-0089	Phase I Open-Label Single-Dose Study of Humanized Mik-Beta-1 Monoclonal Antibody Directed Toward the IL-2R/IL-15R-Beta Subunit (CD122) in T Cell Large Granular Lymphocytic Leukemia
Large granular lymphocyte leukemia	04-C-0031	Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease
Laryngeal cancer	08-C-0071	Phase I Study of Bortezomib and Cetuximab without or with Cisplatin in Combination with Radiation Therapy for Advanced Head and Neck Cancer
Lathosterolosis	02-CH-0311	Investigations into Inborn Errors of Cholesterol Synthesis and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-CH-0311
Leiomyomatosis and renal cell cancer, hereditary	10-C-0114	A Phase II Study of Bevacizumab and Erlotinib in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0114
Leiomyomatosis and renal cell cancer, hereditary	09-C-0072	Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas with Botulinum Toxin	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0072
Leiomyomatosis and renal cell cancer, hereditary	03-C-0066	Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-C-0066
Leiomyomatosis and renal cell cancer, hereditary	89-C-0086	Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-C-0086
Leishmaniasis	10-I-0206	Treatment of Mucocutaneous Leishmaniasis-Mucosal and/or Cutaneous Leishmaniasis-with Miltefosine	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0206
Leishmaniasis	01-I-0238	Diagnosis and Treatment of Leishmanial Infections	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0238
Leukemia, Myeloid	06-H-0062	Safety of WT1 and PR1 Peptide Vaccination for Patients with Myeloid Malignancies
Leukemia, Myeloid	06-C-0227	Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0227
Leukemia, Myeloid	01-H-0162	Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Using RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched, Nonmyeloablative, Peripheral Blood Stem Cell Transplantation for H
Leukemia, Myeloid	97-H-0202	Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults
Leukocyte adhesion deficiency type 1	10-C-0201	Apheresis and CD34+ Selection of Mobilized Peripheral Blood CD34+ Cells from Patients with DOCK8 Deficiency, LAD-1, and MonoMAC	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0201
Leukocyte adhesion deficiency type 1	05-I-0213	Screening and Baseline Assessment of Patients with Abnormalities of Immune Function	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-I-0213
Leukodystrophy	09-HG-0128	Leukodystrophies of Unknown Cause	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-HG-0128
Leukoplakia	02-C-0052	Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0052
Lipodystrophy	03-DK-0257	Effect of Leptin Therapy in the Treatment of Severe Insulin Resistance	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-DK-0257
Lipodystrophy	02-DK-0022	Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-DK-0022
Lipodystrophy	05-I-0127	Assessing the Relationship Between Fatigue and Mitochondrial Toxicity in Patients with HIV/AIDS
Lipodystrophy	05-HG-0004	Clinical Investigations into Hutchison-Gilford Progeria Syndrome
Lipodystrophy	76-DK-0006	Studies of Molecular Genetics of Insulin Secretion, Insulin Action, and Diabetes Mellitus	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1976-DK-0006
Lipodystrophy	07-DK-0212	Prospective Evaluation of Albuminuria in HIV Positive Patients	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-DK-0212
Liver cancer	11-C-0102	A Phase I/II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma (HCC)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0102
Liver cancer	09-C-0138	A Broad Multi-Histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-Small Cell Lung, Head and Neck, Hepatocelluar and Renal Cell Carcinomas and Pheochromocytoma and Thyroid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0138
Liver cancer	04-C-0273	A Phase II Study of Hepatic Arterial Infusion of Melphalan with Venous Filtration via Peripheral Hepatic Perfusion (PHP) for Unresectable Primary and Metastatic Cancers of the Liver	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0273
Liver cancer	09-C-0079	The Natural History of Solid Organ Cancer Stem Cells (SOCSC)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0079
Loiasis	10-I-0101	A Randomized, Placebo-controlled, Double-Blind Pilot Study of Single-Dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa Infection	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0101
Loiasis	88-I-0083	Host Response to Infection and Treatment in the Filarial Diseases of Humans	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1988-I-0083
Lupus nephritis	03-DK-0071	Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy
Lupus nephritis	02-AR-0272	A Phase I, Open-Labeled, Dose-Ascending Clinical Trial of Immunotherapy of MRA, A Humanized Anti-IL 6 Receptor Monoclonal Antibody, In Patients with Systemic Lupus Erythematosus
Lupus nephritis	94-AR-0066	Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-AR-0066
Lupus nephritis	92-DK-0156	Studies of Immunologically-Mediated Kidney Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1992-DK-0156
Lupus nephritis	06-DK-0199	Analysis of Stored Identified Data and Kidney Biopsy Specimens from Patients Enrolled in Protocol 86-DK-0204
Lymphangioleiomyomatosis	08-H-0177	Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (The MILES Trial)
Lymphangioleiomyomatosis	06-H-0222	Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-H-0222
Lymphangioleiomyomatosis	95-H-0186	Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-H-0186
Lymphangioleiomyomatosis	08-H-0016	Effect of Fasting on the Size of Lymphangioleiomyomas in Patients with Lymphangioleiomyomatosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-H-0016
Lymphatic filariasis	10-I-0101	A Randomized, Placebo-controlled, Double-Blind Pilot Study of Single-Dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa Infection	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0101
Lymphatic filariasis	88-I-0083	Host Response to Infection and Treatment in the Filarial Diseases of Humans	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1988-I-0083
Lymphoma AIDSrelated	01-C-0030	Short-Course EPOCH-Rituximab for Untreated CD-20+ HIV-Associated Lymphomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0030
Lymphoma AIDSrelated	97-C-0040	EPOCH Chemotherapy Plus Rituximab for Previously Treated Patients with AIDS-Associated Lymphoma
Lymphoma, large-cell	09-C-0082	Assessment of the Safety and Feasibility of Administering T Cells Expressing an anti-CD19 Chimeric Antigen Receptor to Patients with B-cell Lymphoma or Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0082
Lymphoma, large-cell	05-C-0031	A Randomized Trial of Patient-Specific Vaccination with Conjugated Follicular Lymphoma-Derived Idiotype with Local GM-CSF in First Complete Remission	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-C-0031
Lymphomatoid granulomatosis	94-C-0074	Treatment and Natural History Study of Lymphomatoid Granulomatosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-C-0074
Lynch syndrome	95-HG-0165	Outcomes of Education and Counseling for HNPCC / Lynch Syndrome Testing	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-HG-0165
Malaria	09-CH-0213	Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-CH-0213
Malaria	97-I-0096	Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-I-0096
Malignant fibrous histiocytoma	10-C-0030	A Study of Bevacizumab, a Humanized Monoclonal Antibody Against Vascular Endothelial Growth Factor (VEGF), in Combination with Chemotherapy for Treatment of Osteosarcoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0030
Mansonelliasis	88-I-0083	Host Response to Infection and Treatment in the Filarial Diseases of Humans	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1988-I-0083
Mantle cell lymphoma	10-C-0067	A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0067
Mantle cell lymphoma	09-H-0094	A Pilot Study of the Safety and Efficacy of Escalating Doses of ON 01910.Na in Patients with Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0094
Mantle cell lymphoma	09-C-0082	Assessment of the Safety and Feasibility of Administering T Cells Expressing an anti-CD19 Chimeric Antigen Receptor to Patients with B-cell Lymphoma or Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0082
Mantle cell lymphoma	07-C-0081	A Phase I/II Study of Flavopiridol in Relapsed or Refractory Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma (DLBCL)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0081
Mantle cell lymphoma	05-C-0170	Randomized Phase II Study of Dose-Adjusted EPOCH-Rituximab-Bortezomib (EPOCH-R-B) Induction Followed by Bortezomib Maintenance versus Observation in Untreated Mantle Cell Lymphoma with Microarray Profiling and Proteomics	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-C-0170
Mantle cell lymphoma	01-H-0162	Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Using RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched, Nonmyeloablative, Peripheral Blood Stem Cell Transplantation for H	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-H-0162
Mantle cell lymphoma	00-C-0133	Pilot Study of Idiotype Vaccine and EPOCH-Rituximab Chemotherapy in Untreated Mantle Cell Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-C-0133
Mantle cell lymphoma	10-H-0097	A Study of the Kinetics of Lymphoid Cells in Patients with Monoclonal B-Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers.	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-H-0097
Mastocytosis	03-I-0041	Determining the Pathogenesis of Systemic Pediatric-Onset Mastocytosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-I-0041
Mastocytosis	02-I-0277	Regulation of the Proliferation and Survival of Normal and Neoplastic Human Mast Cells	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-I-0277
Mastocytosis	98-I-0027	The Characterization of CD34+ Derived Mast Cell Precursors Mobilized by Administration of Granulocyte Colony Stimulating Factor and Plerixafor	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1998-I-0027
McCune Albright syndrome	98-D-0146	A Randomized, Placebo-Controlled Trial of Alendronate in the Treatment of Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome
McCune Albright syndrome	98-D-0145	Screening and Natural History of Patients with Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1998-D-0145
Medulloblastoma	09-C-0243	A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-Ribose) Polymerase and Temozolomide in Children with Recurrent/Refractory CNS Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0243
Medulloblastoma	05-C-0132	A Phase I Trial of CC-5013 (Lenalidomide) in Pediatric Patients with Recurrent or Refractory Primary CNS Tumors
Medulloblastoma	01-C-0070	Evaluation of the Natural History of Patients with Tumors of the Central Nervous System	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0070
Melkersson-Rosenthal syndrome	09-N-0182	GABA/Glutamate Balance in Temporal Lobe Epilepsy with and without Major Depression	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-N-0182
Membranous nephropathy	09-DK-0223	Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-DK-0223
Membranous nephropathy	03-DK-0071	Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy
Membranous nephropathy	92-DK-0156	Studies of Immunologically-Mediated Kidney Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1992-DK-0156
Membranous nephropathy	11-DK-0023	Nephrotic Diseases Study Network	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-DK-0023
Meningioma	08-N-0044	A Prospective Natural History Study of Patients with Neurofibromatosis Type 2 (NF2)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-N-0044
Menkes disease	09-CH-0059	Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-CH-0059
Menkes disease	90-CH-0149	Early Copper Histidine Therapy in Menkes Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1990-CH-0149
Methylmalonic acidemia	04-HG-0127	Clinical and Basic Investigations of Methylmalonic Acidemia (MMA) and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-HG-0127
Microcystic adnexal carcinoma	01-I-0202	Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0202
Minimal change disease	05-DK-0015	Retinoids for Podocyte Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-DK-0015
Minimal change disease	03-DK-0226	Pulse Dexamethasone Over 48 Weeks for Podocyte Disease
Minimal change disease	06-DK-0020	Kidney Disease Biomarkers	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-DK-0020
Minimal change disease	11-DK-0023	Nephrotic Diseases Study Network	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-DK-0023
Monoclonal gammopathy of undetermined significance	11-C-0020	A Pilot Study of Novel Imaging Modalities in Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM), and Multiple Myeloma (MM)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0020
Monoclonal gammopathy of undetermined significance	10-C-0096	Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0096
Motor neuron disease	10-N-0121	Oxidative Stress in Motor Neuron Disease: COSMOS-PLS Add-On Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-N-0121
Motor neuron disease	06-N-0174	Cortical Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-N-0174
Motor neuron disease	05-N-0223	Clinical Neurophysiology: Training and Normative Values	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-N-0223
Motor neuron disease	03-N-0203	SMN Levels in Peripheral Blood Samples of SMA Patients and the Effects of Pharmacological Compounds In Vitro
Motor neuron disease	00-N-0043	Clinical and Molecular Manifestations of Inherited Neurological Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-N-0043
Motor neuron disease	06-N-0224	Collection of Blood Samples for DNA Analysis in Motor Neuron Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-N-0224
Muckle-Wells syndrome	10-AR-0182	A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome (FCAS) / Muckle-Wells Syndrome (MWS) and BehcetÕs Disease (BD)
Muckle-Wells syndrome	05-AR-0014	Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects with Autoinflammatory Disease: A Therapeutic Approach to Study Pathogenesis
Muckle-Wells syndrome	94-HG-0105	Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-HG-0105
Muenke Syndrome	05-HG-0131	Clinical Study of Muenke Syndrome (FGFR3-Related Craniosynostosis)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-HG-0131
Multicentric Castleman’s Disease	04-C-0275	Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease with Laboratory and Clinical Correlates of Disease Activity	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0275
Multicentric Castleman’s Disease	11-DK-0023	Nephrotic Diseases Study Network	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-DK-0023
Multiple endocrine neoplasias	11-DK-0114	A Pilot Trial of YF476, A Gastrin Antagonist, in Patients with Type II Gastric Carcinoids Associated with Zollinger-Ellison Syndrome
Multiple endocrine neoplasias	93-DK-0127	Family Studies in Metabolic Diseases and Mineral Metabolism
Multiple endocrine neoplasias	07-C-0189	Phase I/II Trial of Vandetanib (ZD6474, ZACTIMA) in Children and Adolescents with Hereditary Medullary Thyroid Carcinoma
Multiple myeloma	11-C-0024	A Phase II Trial of IPH2101 (Anti-KIR) in Smoldering Multiple Myeloma (SMM)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0024
Multiple myeloma	11-C-0016	Multi-Center Phase I Study of Th1/Tc1 Immunotheraphy Following Autologous Hematopoietic Stem Cell Transplantation in Recently Diagnosed Multiple Myeloma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0016
Multiple myeloma	10-C-0079	A Phase 2 Study of AZD6244 in Multiple Myeloma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0079
Multiple myeloma	09-H-0094	A Pilot Study of the Safety and Efficacy of Escalating Doses of ON 01910.Na in Patients with Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0094
Multiple myeloma	09-C-0224	Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0224
Multiple myeloma	09-C-0210	Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0210
Multiple myeloma	07-H-0136	Selective Depletion of Alloreacting T Cells Using a Photodepletion Technique to Prevent GVHD after HLA-Matched Peripheral Blood Stem Cell Transplantation for Subjects with Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-H-0136
Multiple myeloma	07-C-0195	Pilot Trial of Targeted Immune-Depleting Chemo & Reduced-Intensity Allo Hematopoietic SCT Using 8/8 & 7/8 HLA-Matched Unrelated Donors and Utilizing 2 GVHD Prophy Regimens for the Tx of Leukemias, Lymphomas, & Pre-Malignant Blood Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0195
Multiple myeloma	06-H-0248	Peripheral Blood Stem Cell Allotransplantation for Hematological Malignancies Using a Positive Stem Cell Selection Technique for T Cell Depletion, Followed by Delayed T Cell Add-Back	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-H-0248
Multiple myeloma	04-C-0055	Allogeneic HSCT without Preparative Chemotherapy or with Low-Intensity Preparative Chemotherapy using Sirolimus and Sirolimus-Generated Donor Th2 Cells for Therapy of Refractory Leukemia, Lymphoma, Myeloma, or Myelodysplastic Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0055
Multiple myeloma	03-C-0077	A Pilot Study of EPOCH-F/R Induction Chemotherapy and Reduced-Intensity, HLA-Matched, Related Allogeneic Hematopoietic Stem Cell Transplantation, with Cyclosporine & Methotrexate GVHD Prophylaxis for Refractory or Relapsed Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-C-0077
Multiple myeloma	00-C-0201	Active Immunization of Sibling Stem Cell Transplant Donors Against Purified Myeloma Protein of the Stem Cell Recipient with Multiple Myeloma in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-C-0201
Multiple myeloma	99-H-0050	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-H-0050
Multiple myeloma	99-H-0046	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine
Multiple myeloma	99-C-0143	Pilot Study of Donor Th2 Cells for the Prevention of Graft-Versus-Host Disease in the Setting of Non-Myeloablative, HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-C-0143
Multiple myeloma	97-H-0202	Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults
Multiple myeloma	03-C-0124	Follow-Up Study of Breast Cancer and Multiple Myeloma Subjects Previously Enrolled in Retroviral Gene Transfer Studies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-C-0124
Multiple myeloma	97-H-0099	HLA-Matched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies
Multiple myeloma	11-C-0020	A Pilot Study of Novel Imaging Modalities in Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM), and Multiple Myeloma (MM)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0020
Multiple system atrophy	08-N-0012	L-Dihydroxyphenylserine (L-DOPS) for Norepinephrine Deficiency: Interactions with Carbidopa and Entacapone	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-N-0012
Multiple system atrophy	03-N-0004	Clinical Laboratory Evaluation of Primary Chronic Autonomic Failure	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-N-0004
Muscular dystrophy	00-N-0043	Clinical and Molecular Manifestations of Inherited Neurological Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-N-0043
Mycobacterium Abscessus	01-I-0202	Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0202
Mycobacterium Avium Complex	09-C-0096	Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0096
Mycobacterium Avium Complex	01-I-0202	Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0202
Mycobacterium Chelonae	01-I-0202	Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0202
Mycobacterium Kansasii	01-I-0202	Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0202
Mycosis fungoides	07-C-0133	Phase I Study of Topical Romidepsin (Depsipeptide) in Early Stage Cutaneous T-Cell Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0133
Mycosis fungoides	04-C-0031	Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease
Mycosis fungoides	02-H-0250	A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning with Campath-1H	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-H-0250
Mycosis fungoides	01-C-0049	Phase II Trial of Depsipeptide in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0049
Myelodysplastic syndromes	11-C-0136	Multi-Institutional Prospective Pilot Study of Lupron to Enhance Lymphocyte Immune Reconstitution Following Allogeneic Bone Marrow Transplantation in Post-Pubertal Children and Adults with Molecular Imaging Evaluation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0136
Myelodysplastic syndromes	10-H-0154	Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused with a Reduced Dose of Non-Mobilized Donor T-Cells	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-H-0154
Myelodysplastic syndromes	09-H-0199	A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R agonist), Eltrombopag, in Patients with Low to Int-2 Risk Myelodysplastic Syndrome (MDS)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0199
Myelodysplastic syndromes	09-H-0087	Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0087
Myelodysplastic syndromes	09-C-0210	Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0210
Myelodysplastic syndromes	08-H-0046	Co-Infusion of Umbilical Cord Blood and Haploidentical CD34+ Cells Following Nonmyeloablative Conditioning as Treatment for Severe Aplastic Anemia and MDS Associated with Severe Neutropenia Refractory to Immunosuppressive Therapy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-H-0046
Myelodysplastic syndromes	07-H-0225	A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients with RAEB-1 AND RAEB-2 Myelodysplastic Syndrome (MDS) and AML with Trisomy 8	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-H-0225
Myelodysplastic syndromes	07-H-0159	Efficacy of WT1 and PRI Peptide Vaccination for Patients with Low Risk Myeloid Malignancies
Myelodysplastic syndromes	07-H-0136	Selective Depletion of Alloreacting T Cells Using a Photodepletion Technique to Prevent GVHD after HLA-Matched Peripheral Blood Stem Cell Transplantation for Subjects with Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-H-0136
Myelodysplastic syndromes	07-H-0091	WTI Peptide Vaccination for Patients with High Risk Hematological Malignancies
Myelodysplastic syndromes	07-C-0195	Pilot Trial of Targeted Immune-Depleting Chemo & Reduced-Intensity Allo Hematopoietic SCT Using 8/8 & 7/8 HLA-Matched Unrelated Donors and Utilizing 2 GVHD Prophy Regimens for the Tx of Leukemias, Lymphomas, & Pre-Malignant Blood Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0195
Myelodysplastic syndromes	06-H-0062	Safety of WT1 and PR1 Peptide Vaccination for Patients with Myeloid Malignancies
Myelodysplastic syndromes	05-H-0206	A Pilot Study of Alemtuzumab (Campath[R]) in Patients with Myelodysplastic Syndrome (MDS)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-H-0206
Myelodysplastic syndromes	04-H-0112	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies - Effect of Peritransplant Cyclosporine on Chimerism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-H-0112
Myelodysplastic syndromes	03-H-0192	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies Ã? Effect of Irradiated Donor Lymphocytes on Chimerism
Myelodysplastic syndromes	01-H-0162	Ex Vivo Selective Depletion of Alloreactive Donor T-Lymphocytes Using RFT5-SMPT-dgA, a Specific Anti-Interleukin-2 Receptor Immunotoxin: Reducing GVHD Risk Associated with HLA-Matched, Nonmyeloablative, Peripheral Blood Stem Cell Transplantation for H
Myelodysplastic syndromes	01-C-0125	Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0125
Myelodysplastic syndromes	00-H-0169	A Phase II Study of Antithymocyte Globulin (ATG) and Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)
Myelodysplastic syndromes	99-H-0050	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-H-0050
Myelodysplastic syndromes	99-H-0046	Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T-Cell Add-Back for Hematological Malignancies - Role of Cyclosporine
Myelodysplastic syndromes	97-H-0202	Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults
Myelodysplastic syndromes	04-H-0213	Cytokine Gene Polymorphisms in Bone Marrow Failure
Myelodysplastic syndromes	97-H-0099	HLA-Matched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies
Myelodysplastic syndromes	04-C-0102	Hematologic Malignancy Biology Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0102
Myelofibrosis	03-HG-0313	Genetic Analysis of Gray Platelet Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-HG-0313
Myeloperoxidase deficiency	10-I-0216	Studies of Disorders with Increased Susceptibility to Fungal Infections	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0216
Myositis, inclusion body	91-AR-0196	Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1991-AR-0196
Myxoid liposarcoma	08-C-0080	SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0080
Narcolepsy	06-DK-0079	The Role of the Orexin System in Body Weight Regulation: Patients with Narcolepsy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-DK-0079
Narcolepsy	97-N-0070	Training Protocol for Various Sleep Disorders in Patients with Neurological Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-N-0070
Neonatal stroke	99-N-0045	Study of Abnormal Acquired and Genetic Coagulation Factors in Children with Porencephaly and Stroke
Nephrocalcinosis	92-CH-0011	Treatment of Hypoparathyroidism with Synthetic Human Parathyroid Hormone 1-34	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1992-CH-0011
Nephropathic cystinosis	86-EI-0062	Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1986-EI-0062
Nephropathic cystinosis	78-HG-0093	Natural History Study of the Use of Cysteamine in the Treatment of Cystinosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1978-HG-0093
Nephropathic cystinosis	04-DK-0057	Renal Transplantation in Recipients with Nephropathic Cystinosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-DK-0057
Neuroblastoma	11-C-0073	A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation from Related or Matched Unrelated Donors in Pediatric Patients with Solid Tumors and Leukemias	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0073
Neuroblastoma	11-C-0053	A Phase I Study of Temirolimus in Combination with Irinotecan and Temozolomide in Children, Adolescents, and Young Adults with Relapsed or Refractory Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0053
Neuroblastoma	10-C-0220	Phase I Trial to Evaluate the Safety, Activity and Pharmacokinetics of Marqibo¨ (Vincristine Sulfate Liposomes Injection) in Children and Adolescents with Refractory Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0220
Neuroblastoma	10-C-0178	A Phase 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0178
Neuroblastoma	10-C-0120	A Phase I Study of Pazopanib as a Single Agent for Children with Relapsed or Refractory Solid Tumors, including CNS Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0120
Neuroblastoma	08-C-0007	A Phase I Study of Ipilimumab (Anti-CTLA-4) in Children, Adolescents, and Young Adults with Treatment Refractory Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0007
Neuroblastoma	07-C-0206	A Pilot Study of Tumor Vaccination and R-hIL-7 Following Standard Multimodality Therapy in Patients with High Risk Pediatric Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0206
Neuroblastoma	07-C-0054	A Phase I Trial and Pharmacokinetic Study of Trabectedin (YONDELIS [R], ET-743) in Children and Adolescents with Relapsed or Refractory Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0054
Neuroblastoma	07-C-0040	A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) with or without Interferon Gamma in Patients with Refractory Pediatric Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0040
Neuroblastoma	06-C-0227	Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0227
Neuroblastoma	01-C-0091	Phase I Trial and Pharmacokinetic Study of Tariquidar (XR9576), a P-Glycoprotein Inhibitor, in Combination with Doxorubicin, Vinorelbine or Docetaxel in Pediatric Patients with Refractory Solid Tumors Including Brain Tumors
Neuroblastoma	10-C-0086	Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0086
Neuroblastoma	09-C-0242	Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0242
Neurofibroma	01-C-0222	A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric Patients with Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Neurofibroma	08-C-0079	Natural History Study and Longitudinal Assessment of Children, Adolescents, and Adults with Neurofibromatosis Type 1	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0079
Neurofibroma	05-HG-0152	Variation in Gene Expression in Neurofibromatosis Type 1	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-HG-0152
Neurofibromatosis type 1	08-C-0180	Phase I Trial of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, Nexavar) in Children and Young Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0180
Neurofibromatosis type 1	08-C-0130	A Phase II Trial of Peginterferon Alpha-2b (Pegintron) for Neurofibromatosis Type 1 Related Unresectable, Symptomatic or Life-Threatening Plexiform Neurofibromas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0130
Neurofibromatosis type 1	08-C-0096	A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0096
Neurofibromatosis type 1	06-C-0043	Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Malignant Peripheral Nerve Sheath Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0043
Neurofibromatosis type 1	04-C-0080	Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults with Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Neurofibromatosis type 1	01-C-0222	A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric Patients with Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Neurofibromatosis type 1	08-C-0079	Natural History Study and Longitudinal Assessment of Children, Adolescents, and Adults with Neurofibromatosis Type 1	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0079
Neurofibromatosis type 1	05-HG-0152	Variation in Gene Expression in Neurofibromatosis Type 1	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-HG-0152
Neurofibromatosis type 1	01-C-0027	Natural History of Plexiform in Neurofibromatosis Type I
Neurofibromatosis type 1	09-M-0022	The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory, Pilot Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-M-0022
Neurofibromatosis type 1	06-HG-0134	Natural History and Biology of Dermal Neurofibromas in Neurofibromatosis Type 1
Neurofibromatosis type 2	11-C-0115	Phase 2 Study of Bevacizumab in Children and Adults with Neurofibromatosis Type 2 and Symptomatic Vestibular Schwannoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0115
Neurofibromatosis type 2	10-N-0193	Using Positron Emission Tomography (PET) to Predict Intracranial Tumor Growth in Neurofibromatosis Type II (NF2) Patients	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-N-0193
Neurofibromatosis type 2	08-N-0044	A Prospective Natural History Study of Patients with Neurofibromatosis Type 2 (NF2)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-N-0044
Neurofibromatosis type 2	78-C-0039	Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1978-C-0039
Neuronal ceroid lipofuscinoses	01-CH-0086	A Combination Therapy with Cystagon and N-Acetylcysteine for INCL Patients	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-CH-0086
Nevoid basal cell carcinoma syndrome	78-C-0039	Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1978-C-0039
Niemann-Pick disease	09-CH-0185	Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-CH-0185
Niemann-Pick disease	06-CH-0186	Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-CH-0186
Non-small cell lung cancer	11-C-0096	Pilot Trial of Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0096
Non-small cell lung cancer	10-C-0218	Randomized Phase II Study of AZD6244 MEK-Inhibitor with Erlotinib in KRAS Wild Type and KRAS Mutant Advanced Non-Small Cell Lung Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0218
Non-small cell lung cancer	10-C-0189	A Phase 1, Dose Escalation Study of MGAH22 (Fc-Optimized Chimeric Anti-HER2 Monoclonal Antibody) in Patients with Refractory HER2 Positive Breast Cancer and Patients with Other HER2 Positive Carcinomas for Whom no Standard Therapy is Available	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0189
Non-small cell lung cancer	10-C-0138	Allogeneic Tumor Cell Vaccine with Metronomic Oral Cyclophosphamide and Celecoxib as Adjuvant Therapy for Lung and Esophageal Cancers, Thymic Neoplasms, Thoracic Sarcomas, and Malignant Pleural Mesotheliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0138
Non-small cell lung cancer	10-C-0071	Phase 2, Open-Label Arm Study of the Efficacy and Safety of PF-02341066 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring a Translocation or Inversion Involving the Anaplastic Lymphoma Kinase (ALK) Gene Locus	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0071
Non-small cell lung cancer	10-C-0070	A Phase 3, Randomized, Open-Label Study of the Efficacy and Safety of PF-02341066 Versus Standard of Care Chemotherapy in Subjects with Advanced NSCLC Harboring a Translocation or Inversion Event Involving the Anaplastic Lymphoma Kinase (ALK) Gene Locus
Non-small cell lung cancer	10-C-0051	A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin suppressor) in Subjects with Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0051
Non-small cell lung cancer	10-C-0032	A Phase I Trial of SS1 (dsFv) PE38 with Paclitaxel, Carboplatin, and Bevacizumab in Subjects with Unresectable Non-Small Cell Lung Adenocarcinoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0032
Non-small cell lung cancer	09-C-0235	A Phase 2, Open-Label, Trial of PF-00299804 in Selected Patients with Advanced Adenocarcinoma of the Lung	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0235
Non-small cell lung cancer	09-C-0214	A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine (FdCyd + THU)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0214
Non-small cell lung cancer	09-C-0138	A Broad Multi-Histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-Small Cell Lung, Head and Neck, Hepatocelluar and Renal Cell Carcinomas and Pheochromocytoma and Thyroid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0138
Non-small cell lung cancer	09-C-0107	Phase II Study of Neoadjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2), Non-Squamous Cell Non-Small Cell Lung Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0107
Non-small cell lung cancer	09-C-0080	A Phase 2, Open-label, Proof-of-Concept Study to Assess the Ability to Detect Tumours and Angiogenesis via the Expression of Alpha v Beta 3 Integrin Receptors by (18F)AH-111585 PET Imaging	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0080
Non-small cell lung cancer	09-C-0018	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Oral Talactoferrin in Addition to Best Supportive Care in Adults with Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Two or More Prior Treatment Regimens	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0018
Non-small cell lung cancer	08-C-0166	An Open Label Pilot Study to Evaluate the Effect on the Immune System of Talactoferrin in Adults with Non-Small Cell Lung Cancer (NSCLC)
Non-small cell lung cancer	08-C-0086	A Phase 2, Open-Label, Two Arm Trial to Evaluate the Efficacy of PF-00299804 in Patients with Advanced NSCLC after Failure of at Least One Prior Chemotherapy Regimen and Failure of Prior Treatment with Erlotinib	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0086
Non-small cell lung cancer	08-C-0083	Registration Ph III Study of Lucanix ª in Adv NSC Lung Cancer: An Intl Mltctr RDBPC Study of Lucanixª Maint Ther for Stages III/IV NSCLC Subjects Who Have Responded to or Have Stable Disease Following One Reg of Front-Line, Platinum-Based Comb Chemo	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0083
Non-small cell lung cancer	08-C-0078	A Phase II Trial of Pemetrexed (Alimta [Registered Trademark]) Combined with Sirolimus (Rapamycin, Rapamune [Registered Trademark]) in Subjects with Relapsed or Refractory NSCLC	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0078
Non-small cell lung cancer	08-C-0075	Phase III Evaluation of Recombinant MAGE-A3 Vaccine as Adjuvant Therapy Following Resection of MAGE-A3-Positive Non-Small Cell Lung Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0075
Non-small cell lung cancer	06-C-0227	Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0227
Non-small cell lung cancer	05-C-0049	Phase II Study of Bay 43-9006 (Sorafenib) with Evaluation of RAS Signal Pathway in Patients with Relapsed Non-Small Cell Lung Cancer
Non-small cell lung cancer	05-C-0010	Phase I Study of Sequential Depsipeptide/Flavopiridol Infusion for Malignancies Involving Lungs, Esophagus, Pleura, Thymus or Mediastinum	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-C-0010
Non-small cell lung cancer	04-C-0049	A Phase I/II Study of an Antitumor Vaccination Using Alpha (1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients with Refractory or Recurrent Non-Small Cell Lung Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0049
Non-small cell lung cancer	02-C-0205	Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion with or without Concurrent Celecoxib in Subjects with Pulmonary and Pleural Malignancies
Non-small cell lung cancer	10-C-0170	Lung Cancer Mutation Consortium Protocol	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0170
Non-small cell lung cancer	11-C-0044	Frequency of Epidermal Growth Factor Receptor Mutations in Latinos/Hispanics with Non-Small Lung Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0044
Non-small cell lung cancer	09-C-0103	Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0103
Occipital horn syndrome	09-CH-0059	Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-CH-0059
Ochronosis	00-HG-0141	Clinical, Biochemical, and Molecular Investigations into Alkaptonuria	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-HG-0141
Ocular melanoma	06-C-0088	A Random-Assignment Study of Hepatic Arterial Infusion of Melphalan with Venous Filtration via Peripheral Hepatic Perfusion (PHP) (Delcath System) Versus Best Alternative Care for Ocular and Cutaneous Melanoma Metastatic to the Liver	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-C-0088
Oculocutaneous albinism type 2	09-HG-0035	Clinical, Cellular, and Molecular Investigations into Oculocutaneous Albinism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-HG-0035
Oculocutaneous albinism type 2	09-HG-0035	Clinical, Cellular, and Molecular Investigations into Oculocutaneous Albinism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-HG-0035
Oligoastrocytoma	11-C-0081	(11C)N-Desmethyl-Loperamide as a Marker of P-Glycoprotein Function in Patients with Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0081
Oligodendroglioma	09-C-0080	A Phase 2, Open-label, Proof-of-Concept Study to Assess the Ability to Detect Tumours and Angiogenesis via the Expression of Alpha v Beta 3 Integrin Receptors by (18F)AH-111585 PET Imaging	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0080
Oligodendroglioma	03-N-0164	Evaluation and Treatment of Neurosurgical Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-N-0164
Onchocerciasis	88-I-0083	Host Response to Infection and Treatment in the Filarial Diseases of Humans	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1988-I-0083
Oncocytoma renal	89-C-0086	Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-C-0086
Optic neuritis	11-N-0116	Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People with Multiple Sclerosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-N-0116
Oral cancer	10-D-0180	A Pilot Trial Targeting mTOR as a Novel Mechanism-Based Neoadjuvant Therapy for Head and Neck Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-D-0180
Oral cancer	08-C-0071	Phase I Study of Bortezomib and Cetuximab without or with Cisplatin in Combination with Radiation Therapy for Advanced Head and Neck Cancer
Organic acidemia	04-HG-0127	Clinical and Basic Investigations of Methylmalonic Acidemia (MMA) and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-HG-0127
Osteogenesis imperfecta	00-CH-0136	A Trial of Pamidronate in Children with Osteogenesis Imperfecta	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-CH-0136
Osteogenesis imperfecta	92-CH-0034	Studies of Growth Deficiency and Growth Hormone Treatment in Children with Osteogenesis Imperfecta Types III and IV	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1992-CH-0034
Osteogenesis imperfecta	97-CH-0064	Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-CH-0064
Osteomalacia	89-DK-0173	Studies of States with Resistance to Vitamin D and Parathyroid Hormone	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-DK-0173
Osteomalacia	01-D-0184	Evaluation and Treatment of Bone and Mineral Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-D-0184
Osteonecrosis	98-I-0070	Magnetic Resonance Imaging to Study Avascular Necrosis in HIV-Infected Subjects	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1998-I-0070
Osteosarcoma	10-C-0178	A Phase 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0178
Osteosarcoma	10-C-0120	A Phase I Study of Pazopanib as a Single Agent for Children with Relapsed or Refractory Solid Tumors, including CNS Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0120
Osteosarcoma	10-C-0030	A Study of Bevacizumab, a Humanized Monoclonal Antibody Against Vascular Endothelial Growth Factor (VEGF), in Combination with Chemotherapy for Treatment of Osteosarcoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0030
Osteosarcoma	09-C-0104	A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Phase II.5 Study of Saracatinib (AZDO53O), a Selective Src Kinase Inhibitor, In Patients with Recurrent Osteosarcoma Localized to the Lung	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0104
Osteosarcoma	08-C-0080	SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0080
Osteosarcoma	07-C-0040	A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) with or without Interferon Gamma in Patients with Refractory Pediatric Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0040
Osteosarcoma	99-C-0125	Osteosarcoma: Outcome of Therapy Based on Histologic Response: A Collaborative Effort of the POB/NCI, Texas Children's Hospital and University of Oklahoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-C-0125
Osteosarcoma	09-C-0054	A Group Wide Biology and Banking Study for Phase II Study of R1507	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0054
Osteosarcoma	98-C-0037	Treatment of Children with Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1998-C-0037
Ovarian cancer	11-C-0080	Ph II Randomized Trial of the Combination of ABT-888 with Metronomic Oral Cyclophosphamide in Refractory BRCA-Pos Ovarian, Primary Peritoneal or Ovarian High-Grade Serous Carcinoma, Fallopian Tube Cancer, Triple-Neg Breast Cancer, and Low-Grade NHL	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0080
Ovarian cancer	11-C-0061	Phase I Trial of Z-Endoxifen in Adults with Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or other Hormone Receptor-Positive Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0061
Ovarian cancer	11-C-0022	A Pharmacokinetic/Pharmacodynamic Study with a Phase I Run-In with a PARP Inhibitor (Olaparib) in Combination with Carboplatin for Refractory or Recurrent Women's Cancers	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0022
Ovarian cancer	10-C-0189	A Phase 1, Dose Escalation Study of MGAH22 (Fc-Optimized Chimeric Anti-HER2 Monoclonal Antibody) in Patients with Refractory HER2 Positive Breast Cancer and Patients with Other HER2 Positive Carcinomas for Whom no Standard Therapy is Available	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0189
Ovarian cancer	10-C-0028	Phase II Study of Clinical Activity of Pegaspargase in Women with Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0028
Ovarian cancer	09-C-0089	A Targeted Ph I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ¨), in Adults with Solid Tumors with a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Ca (MTC)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0089
Ovarian cancer	08-C-0092	A Phase I Study with an Expansion Cohort of the PARP Inhibitor AZD2281 Combined with Carboplatin in BRCA1/2 Familial Breast and Ovarian Cancer and Sporadic Triple Negative Breast and Ovarian Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0092
Ovarian cancer	08-C-0074	A Phase II Study of Satraplatin and Prednisone in Metastatic Androgen Independent Prostate Cancer (AIPC)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0074
Ovarian cancer	07-C-0061	Phase II Study of Clinical Activity and Proteomic Pathway Profiling of the VEGFR2 Inhibitor, Vandetanib in Women With Relapsed or Refractory Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Ovarian cancer	07-C-0058	A Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian, Fallopian, and Peritoneal Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0058
Ovarian cancer	04-C-0246	An Open Label Pilot Study to Evaluate the Safety and Tolerability of PANVAC-V (Vaccinia) and PANVAC-F (Fowlpox) in Combination with Sargramostim in Adults with Metastatic Carcinoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0246
Ovarian cancer	03-C-0284	A Clinical Trial of the P-Glycoprotein Antagonist, Tariquidar (XR9576), in Combination With Docetaxel in Patients With Lung, Ovarian, Renal and Cervical Cancer: Analysis of the Interaction Between Tariquidar and Docetaxel
Ovarian cancer	00-C-0121	A Phase I Investigation of IL-12/Pulse IL-2 in Adults with Advanced Solid Tumors
Ovarian cancer	99-C-0137	Vaccine Therapy with Tumor Specific p53 Peptides in Adult Patients with Low Burden Adenocarcinoma of the Ovary
Ovarian cancer	95-C-0055	A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin with G-CSF for Patients with Newly Diagnosed Advanced Stage Ovarian Cancer
Ovarian cancer	04-C-0232	A Multi-Institutional Study of Proteomic Evaluation of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile of Relapse	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0232
Ovarian cancer	02-C-0268	Prospective Study of Prophylactic Salpingo-Oophorectomy and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk of Ovarian Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0268
Ovarian cancer	02-C-0212	Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0212
Ovarian cancer	01-C-0008	Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Pilot Study
Ovarian cancer	00-C-0018	A Pilot Study of Proteomic Evaluation of Epithelial Ovarian Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile Associated with Relapse	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-C-0018
Ovarian cancer	99-C-0081	Methods in Education for Breast Cancer Genetics
Ovarian cancer	95-HG-0165	Outcomes of Education and Counseling for HNPCC / Lynch Syndrome Testing	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-HG-0165
Ovarian cancer	11-C-0033	Extended Follow-up of High Ovarian Cancer Risk Cohort from 02-C-0268 (GOG-199)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0033
Ovarian cancer	10-C-0028	Phase II Study of Clinical Activity of Pegaspargase in Women with Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0028
Ovarian cancer	07-C-0061	Phase II Study of Clinical Activity and Proteomic Pathway Profiling of the VEGFR2 Inhibitor, Vandetanib in Women With Relapsed or Refractory Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Ovarian cancer	00-C-0018	A Pilot Study of Proteomic Evaluation of Epithelial Ovarian Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile Associated with Relapse	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-C-0018
Pallister-Hall syndrome	94-HG-0193	Genetic and Clinical Studies of Congenital Anomaly Syndromes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-HG-0193
Pancreatic cancer	11-C-0100	A Pilot Study to Test the Feasibility of the Combination of Gemcitabine and CT-011 in the Treatment of Resected Pancreatic Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0100
Pancreatic cancer	11-C-0099	Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0099
Pancreatic cancer	08-H-0186	Safety and the Anti-Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NKÃ?TRAIL Cytotoxicity with Bortezomib	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-H-0186
Pancreatic cancer	07-C-0111	A Pilot Study of Markers of Tumor Burden and Radiation Toxicity in the Blood, Urine, and Stool of Patients Receiving Radiotherapy for Gastrointestinal Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0111
Pancreatic cancer	05-C-0044	Immunologic Studies of Tumors of the Pancreas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-C-0044
Pancreatic islet cell tumors	04-C-0273	A Phase II Study of Hepatic Arterial Infusion of Melphalan with Venous Filtration via Peripheral Hepatic Perfusion (PHP) for Unresectable Primary and Metastatic Cancers of the Liver	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0273
Pancreatic islet cell tumors	09-C-0161	Follow Up Protocol for Subjects Previously Enrolled in NCI Surgery Branch Studies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0161
Pancreatic islet cell tumors	03-C-0145	Evaluation of the Natural History and Management of Pancreatic Lesions Associated with Von Hippel-Lindau	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-C-0145
Pancreatic islet cell tumors	90-DK-0137	Evaluation of the Gastrinoma in Patients with Zollinger-Ellison Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1990-DK-0137
Pancreatic islet cell tumors	09-C-0242	Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0242
PANDAS	11-M-0058	A Placebo-Controlled Trial of Intravenous Immunoglobulin (IVIG) for PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-M-0058
Panuveitis	06-EI-0050	Multicenter Uveitis Steroid Treatment (MUST) Trial Protocol	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-EI-0050
Papillary renal cell carcinoma	07-C-0121	A Phase 2 Study of the C-Met RTK Inhibitor Foretinib (Formerly GSK 1363089) in Subjects with Papillary Renal-Cell Carcinoma (PRC)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0121
Papilledema	03-AR-0298	A Long-Term Outcome Study with the IL-1 Receptor Antagonist anakinra/Kineret¨ in Patients with Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome) A Therapeutic Approach to Study the Pathogenesis of this Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-AR-0298
Papilledema	03-AR-0173	Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CRMO, StillÕs Disease, BehcetÕs Disease, and other Undifferentiated Autoinflammatory Diseases)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-AR-0173
Paragonimiasis	77-I-0094	Study of Patients with Parasitic Infections of the Gastrointestinal Tract	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1977-I-0094
Paroxysmal nocturnal hemoglobinuria	10-H-0154	Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused with a Reduced Dose of Non-Mobilized Donor T-Cells	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-H-0154
Paroxysmal nocturnal hemoglobinuria	03-H-0249	A Randomized Trial of Immunosupression in Aplastic Anemia Patients with Refractory Pancytopenia or Suboptimal Hematologic Response after h-ATG/CsA Treatment	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-H-0249
Paroxysmal nocturnal hemoglobinuria	99-H-0050	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-H-0050
Paroxysmal nocturnal hemoglobinuria	97-H-0117	A Randomized Trial of Antithymocyte Globulin and Cyclosporine versus Cyclophosphamide and Cyclosporine in the Treatment of Severe Aplastic Anemia
Paroxysmal nocturnal hemoglobinuria	04-H-0161	Studies of the Natural History of Sickle Cell Disease and Other Hemolytic Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-H-0161
Pars planitis	06-EI-0068	The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-EI-0068
Pearson marrow-pancreas syndrome	02-C-0052	Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0052
Pendred syndrome	01-DC-0228	Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-DC-0228
Pentalogy of Cantrell	04-H-0202	Human Diseases with Mutation of Non-Muscle Myosin Heavy Chain Genes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-H-0202
Peripheral T-cell lymphoma	08-C-0164	A Phase II, Multicenter, Open-Label Trial Evaluating the Activity and Tolerability of Romidepsin (Depsipeptide, FK228) in Progressive or Relapsed Peripheral T-cell Lymphoma Following Prior Systemic Therapy
Peripheral T-cell lymphoma	04-C-0031	Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease
Peripheral T-cell lymphoma	01-C-0049	Phase II Trial of Depsipeptide in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0049
Peripheral T-cell lymphoma	97-C-0110	Phase I/II Study of Tac-Expressing Malignancies Other than Adult T-Cell Leukemia (ATL) with Yttrium-90 Radiolabeled Humanized Anti-Tac and Calcium-DTPA	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-C-0110
Peutz-Jeghers syndrome	95-CH-0059	Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-CH-0059
Pheochromocytoma	09-C-0138	A Broad Multi-Histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-Small Cell Lung, Head and Neck, Hepatocelluar and Renal Cell Carcinomas and Pheochromocytoma and Thyroid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0138
Pheochromocytoma	11-C-0149	Evaluation of Diagnostic and Prognostic Molecular Markers in Adrenal Neoplasm	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0149
Pheochromocytoma	00-CH-0093	Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-CH-0093
Piebaldism	10-I-0148	Natural History of Atopic Dermatitis and Other Genetic/Congenital Diseases Associated with Allergic Inflammation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0148
Piebaldism	09-I-0086	Screening Protocol for Genetic Diseases of Mast Cell Homeostasis and Activation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-I-0086
Pineocytoma	11-C-0053	A Phase I Study of Temirolimus in Combination with Irinotecan and Temozolomide in Children, Adolescents, and Young Adults with Relapsed or Refractory Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0053
Pineocytoma	10-C-0175	A Phase I Study of IMC-A12 (Anti-Insulin-like Growth Factor-I Receptor Monoclonal Antibody) in Combination with CCI-779 (Temsirolimus) in Pediatric Patients with Recurrent or Refractory Solid Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0175
Platelet storage pool deficiency	07-HG-0132	Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-HG-0132
Platelet storage pool deficiency	97-HG-0085	Therapeutic Clinical Trial of Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1997-HG-0085
Platelet storage pool deficiency	95-HG-0193	Clinical and Basic Investigations into Hermansky-Pudlak Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-HG-0193
Pleuropulmonary blastoma	11-C-0034	Dicer1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0034
Polydactyly	94-HG-0193	Genetic and Clinical Studies of Congenital Anomaly Syndromes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-HG-0193
Polydactyly	04-HG-0123	Bardet-Biedl Syndrome: Phenotype and Metabolic Characteristics	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-HG-0123
Polymorphic reticulosis	10-D-0180	A Pilot Trial Targeting mTOR as a Novel Mechanism-Based Neoadjuvant Therapy for Head and Neck Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-D-0180
Polymyositis	07-E-0012	Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
Polymyositis	02-AR-0156	A Randomized, Double-Blind, Placebo-Controlled Trial of Infliximab In Patients With Dermatomyositis and Polymyositis
Polymyositis	94-E-0165	Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-E-0165
Polymyositis	91-AR-0196	Studies on the Natural History and Pathogenesis of Polymyositis, Dermatomyositis, and Related Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1991-AR-0196
Porencephaly	99-N-0045	Study of Abnormal Acquired and Genetic Coagulation Factors in Children with Porencephaly and Stroke
Portal hypertension	91-DK-0214	Evaluation of Patients with Liver Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1991-DK-0214
Precocious puberty	98-D-0146	A Randomized, Placebo-Controlled Trial of Alendronate in the Treatment of Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome
Precocious puberty	06-CH-0011	Natural History Study of Patients with Excess Androgen	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-CH-0011
Premature aging	05-HG-0004	Clinical Investigations into Hutchison-Gilford Progeria Syndrome
Primary biliary cirrhosis	91-DK-0214	Evaluation of Patients with Liver Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1991-DK-0214
Primary ciliary dyskinesia	09-I-0172	Natural History of Bronchiectasis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-I-0172
Primary ciliary dyskinesia	06-I-0217	Genetic Disorders of Mucociliary Clearance	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-I-0217
Primary ciliary dyskinesia	08-I-0067	Ciliary Dysfunction as an Underlying Etiology Linking Primary Ciliary Dyskinesia with Heterotaxy and Complex Congenital Heart Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-I-0067
Primary effusion lymphoma	97-C-0040	EPOCH Chemotherapy Plus Rituximab for Previously Treated Patients with AIDS-Associated Lymphoma
Primary immunodeficiency disorders	00-HG-0209	Molecular and Clinical Studies of Primary Immunodeficiency Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-HG-0209
Primary immunodeficiency disorders	99-AR-0004	Molecular Basis of Primary Immunodeficiencies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-AR-0004
Primary lateral sclerosis	10-N-0121	Oxidative Stress in Motor Neuron Disease: COSMOS-PLS Add-On Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-N-0121
Primary lateral sclerosis	06-N-0174	Cortical Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-N-0174
Primary lateral sclerosis	06-N-0224	Collection of Blood Samples for DNA Analysis in Motor Neuron Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-N-0224
Primary sclerosing cholangitis	91-DK-0214	Evaluation of Patients with Liver Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1991-DK-0214
Progeria	05-HG-0004	Clinical Investigations into Hutchison-Gilford Progeria Syndrome
Progressive multifocal leukoencephalopathy	99-C-0088	(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who Receive Neurotoxic Therapy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-C-0088
Progressive multifocal leukoencephalopathy	10-I-0014	The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients without Known Immunocompromise	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0014
Proteus syndrome	94-HG-0132	The Phenotype and Etiology of Proteus Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-HG-0132
Pseudohypoparathyroidism	93-DK-0127	Family Studies in Metabolic Diseases and Mineral Metabolism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1993-DK-0127
Pseudohypoparathyroidism	89-DK-0173	Studies of States with Resistance to Vitamin D and Parathyroid Hormone	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-DK-0173
Pure red cell aplasia	10-H-0154	Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused with a Reduced Dose of Non-Mobilized Donor T-Cells	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-H-0154
Pure red cell aplasia	05-H-0206	A Pilot Study of Alemtuzumab (Campath[R]) in Patients with Myelodysplastic Syndrome (MDS)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-H-0206
Pure red cell aplasia	00-H-0029	A Pilot Study of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) in Patients with Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-H-0029
Pure red cell aplasia	99-H-0050	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-H-0050
Pure red cell aplasia	04-H-0213	Cytokine Gene Polymorphisms in Bone Marrow Failure
Pure red cell aplasia	02-C-0052	Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0052
Pyoderma gangrenosum	94-HG-0105	Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-HG-0105
Rabies	01-I-0226	Evaluation of Immune Response to Vaccines in Primary Immune Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0226
Rasmussen encephalitis	0	Shigella Sonnel O-SPC/rBRU Conjugate Vaccine
Rasmussen encephalitis	0	Withdrawal of Therapy After Long-Term Oral Nucleos(t)ide Analogue Treatment in Patients with Chronic Hepatitis B
Renal cancer	11-C-0013	Phase I/II Study of Metastatic Cancer Using Lymphodepleting Conditioning Followed by Infusion of Anti-VEGFR2 Gene Engineered CD8+ Lymphocytes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0013
Renal cancer	10-C-0114	A Phase II Study of Bevacizumab and Erlotinib in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0114
Renal cancer	10-C-0078	A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0078
Renal cancer	09-C-0092	Phase 1/2 Study of Metastatic Renal Cancer using T-Cells Transduced with a T-Cell Receptor which Recognizes TRAIL Bound to the DR4 Receptor	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0092
Renal cancer	09-C-0089	A Targeted Ph I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ¨), in Adults with Solid Tumors with a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Ca (MTC)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0089
Renal cancer	08-C-0020	A Phase 2 Study of ZD6474 (Vandetanib) in Patients with Von Hippel Lindau Disease and Renal Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0020
Renal cancer	07-C-0121	A Phase 2 Study of the C-Met RTK Inhibitor Foretinib (Formerly GSK 1363089) in Subjects with Papillary Renal-Cell Carcinoma (PRC)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0121
Renal cancer	04-C-0177	A Pilot Study of Tc-94m Sestamibi PET MDR Imaging	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0177
Renal cancer	03-C-0284	A Clinical Trial of the P-Glycoprotein Antagonist, Tariquidar (XR9576), in Combination With Docetaxel in Patients With Lung, Ovarian, Renal and Cervical Cancer: Analysis of the Interaction Between Tariquidar and Docetaxel
Renal cancer	03-C-0066	Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-C-0066
Renal cancer	02-C-0159	The Birt Hogg-Dube Syndrome: Identification of the Disease Gene and Characterization of the Predisposition of Renal Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0159
Renal cancer	89-C-0086	Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-C-0086
Renal cancer	10-C-0086	Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0086
Retinal degeneration	06-EI-0236	National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-EI-0236
Retinal degeneration	05-EI-0143	Molecular Genetics of Retinal Degenerations	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-EI-0143
Retinitis pigmentosa	06-EI-0236	National Ophthalmic Genotyping and Phenotyping Network, Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-EI-0236
Retinitis pigmentosa	05-EI-0096	Natural History and Genetic Studies of Usher Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-EI-0096
Retinitis pigmentosa	05-EI-0143	Molecular Genetics of Retinal Degenerations	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-EI-0143
Retinoblastoma	95-HG-0158	Genetic Analysis of Hereditary Prostate Cancer
Retinoblastoma	10-C-0086	Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0086
Revesz syndrome	02-C-0052	Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0052
Rhabdomyosarcoma 1	02-C-0259	Pilot Study of Allogeneic/Syngeneic Blood Stem Cell Transplantation in Patients with High-Risk and Recurrent Pediatric Sarcomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0259
Rhabdomyosarcoma 1	97-C-0052	A Pilot Study of Autologous T-Cell Transplantation with Vaccine Driven Expansion of Anti-Tumor Effectors after Cytoreductive Therapy in Metastatic Pediatric Sarcomas
Rhabdomyosarcoma 1	97-C-0050	A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 with or without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas
Rickets	89-DK-0173	Studies of States with Resistance to Vitamin D and Parathyroid Hormone	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-DK-0173
Sarcoidosis	06-H-0072	Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-H-0072
Sarcoidosis	06-H-0222	Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-H-0222
Sarcoidosis	96-H-0100	Role of Genetic Factors in the Pathogenesis of Lung Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1996-H-0100
SARS	08-I-0093	A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Topical Nasal Poly-ICLC
SARS	10-I-0197	Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0197
Schwannoma	08-N-0044	A Prospective Natural History Study of Patients with Neurofibromatosis Type 2 (NF2)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-N-0044
Senior Loken Syndrome	03-HG-0264	Clinical Investigations into the Kidney and Liver Disease in Autosomal Recessive Polycystic Kidney Disease/Congenital Hepatic Fibrosis and other Ciliopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-HG-0264
Sertoli-leydig cell tumors	11-C-0034	Dicer1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0034
Severe combined immunodeficiency	11-I-0007	Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age with X-Linked Severe Combined Immunodeficiency	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-I-0007
Severe combined immunodeficiency	10-I-0139	Searching for Persistence of Infection in Lyme Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0139
Severe combined immunodeficiency	07-I-0171	Treatment for Growth Failure in Patients with X-Linked Severe Combined Immunodeficiency (XSCID): A Phase 2 Study Assessing Safety and Clinical Response to Treatment with Insulin-like Growth Factor-1 (IGF-1)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-I-0171
Severe combined immunodeficiency	04-C-0031	Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease
Severe combined immunodeficiency	02-I-0057	Ex Vivo Retroviral Gene Transfer For Treatment of X-Linked Severe Combined Immunodeficiency (XSCID)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-I-0057
Severe combined immunodeficiency	01-HG-0189	Treatment of SCID due to ADA Deficiency with Autologous Cord Blood or Bone Marrow CD34+ Cells Transduced with a Human ADA Gene	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-HG-0189
Severe combined immunodeficiency	09-I-0133	Establishing Fibroblast-derived Cell Lines from Skin Biopsies of Patients with Immunodeficiency or Immunodysregulation Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-I-0133
Severe combined immunodeficiency	01-H-0198	Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-H-0198
Severe combined immunodeficiency	95-I-0066	Genetic Analysis of Immune Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-I-0066
Severe combined immunodeficiency	94-I-0073	Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-I-0073
Severe combined immunodeficiency	10-HG-0151	Quality of Life and Neuropsychiatric Sequelae in Patients Treated with Gene Therapy for ADA-SCID and in their Parents	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-HG-0151
Severe combined immunodeficiency	03-H-0105	The Determination of Genetic Basis Of Immunodeficiency	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-H-0105
Severe combined immunodeficiency	05-I-0213	Screening and Baseline Assessment of Patients with Abnormalities of Immune Function	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-I-0213
Sezary syndrome	02-H-0250	A Phase I/II Study of HLA-matched Mobilized Peripheral Blood Hematopoietic Stem Cell Transplantation for Advanced Mycosis Fungoides/Sezary Syndrome Using Nonmyeloablative Conditioning with Campath-1H	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-H-0250
Sezary syndrome	01-C-0049	Phase II Trial of Depsipeptide in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-C-0049
Shigellosis	0	Shigella Sonnel O-SPC/rBRU Conjugate Vaccine
Shwachman-Diamond syndrome	02-C-0052	Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0052
Sickle cell anemia	11-H-0121	Pilot Trial of the Safety and Efficacy of Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients with Hemolytic Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-H-0121
Sickle cell anemia	10-H-0031	THE IMPROVE TRIAL: Improving Pain Management and Outcomes with Various Strategies of Patient-Controlled Analgesia (PCA)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-H-0031
Sickle cell anemia	09-H-0225	Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Beta-Thalassemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0225
Sickle cell anemia	07-H-0196	Niacin Therapy to Improve Endothelial Function in Sickle Cell Disease
Sickle cell anemia	07-H-0177	Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-H-0177
Sickle cell anemia	07-CC-0011	Hypnosis as a Pain and Symptom Management Strategy in Patients with Sickle Cell Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-CC-0011
Sickle cell anemia	06-H-0202	Cardiopulmonary Function Assessment and NO Based Therapies for Patients with Hemolysis-Associated Pulmonary Hypertension
Sickle cell anemia	06-H-0054	Evaluation of Synergy of Combining Hydroxyurea with Recombinant Human Erythropoietin Glycoform Alpha (rhu Erythropoietin-alpha) on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia
Sickle cell anemia	05-H-0019	A Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis
Sickle cell anemia	05-H-0016	Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease
Sickle cell anemia	04-CC-0032	Atorvastatin Therapy To Improve Endothelial Function in Sickle Cell Disease
Sickle cell anemia	03-H-0170	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Severe Congenital Anemias Including Sickle Cell Disease, Thalassemia, and Diamond Blackfan Anemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-H-0170
Sickle cell anemia	03-CC-0127	Evaluation of Potential Synergy of Combining Hydroxyurea with Nitric Oxide Donors on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia
Sickle cell anemia	01-H-0223	Inhaled Nitric Oxide and Transfusion Therapy for Patients with Sickle Cell Anemia and Secondary Pulmonary Hypertension
Sickle cell anemia	84-H-0029	Effect of Hydroxyurea on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia
Sickle cell anemia	07-H-0181	Pulmonary Hypertension and the Hypoxic Response in SCD	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-H-0181
Sickle cell anemia	04-H-0161	Studies of the Natural History of Sickle Cell Disease and Other Hemolytic Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-H-0161
Sickle cell anemia	03-H-0015	Collection of Blood from Volunteers and Patients for Studies of Endothelial Function and Systemic Inflammation	http://clinicalstudies.info.nih.gov/cgi/wais/bold032001.pl?A_03-H-0015.html@03-H-0015
Sickle cell anemia	01-H-0122	Collection and Storage of Umbilical Cord Hematopoietic Stem Cells for Sickle Cell Disease Therapy	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-H-0122
Sickle cell anemia	01-H-0088	Determining the Prevalence and Prognosis of Secondary Pulmonary Hypertension in Adult Patients with Sickle Cell Anemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-H-0088
Sickle cell anemia	08-H-0156	Screening of Subjects to Determine Eligibility to Safely Participate in Blood Disorders Studies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-H-0156
Sickle cell anemia	08-DK-0004	High Throughput Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-DK-0004
Sideroblastic anemia pyridoxine-refractory autosomal recessive	99-H-0050	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in High Risk Patients and in Patients with Debilitating Hematologic Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-H-0050
Sitosterolemia	07-DK-0219	A Nutrigenomics Intervention for the Study of the Role of Dietary Sitosterol on Lipid, Glucose and Energy Metabolism	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-DK-0219
Situs inversus	03-HG-0264	Clinical Investigations into the Kidney and Liver Disease in Autosomal Recessive Polycystic Kidney Disease/Congenital Hepatic Fibrosis and other Ciliopathies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-HG-0264
Situs inversus	08-I-0067	Ciliary Dysfunction as an Underlying Etiology Linking Primary Ciliary Dyskinesia with Heterotaxy and Complex Congenital Heart Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-I-0067
Smallpox	11-I-0128	A Multicenter, Open-Label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-I-0128
Smallpox	08-I-0093	A Phase I Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety and Tolerability of Topical Nasal Poly-ICLC
Smallpox	03-I-0090	Immune Responses to Vaccinia Virus Vaccination	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-I-0090
Smith-Lemli-Opitz syndrome type 1	03-CH-0225	Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
Smith-Lemli-Opitz syndrome type 1	98-CH-0081	Clinical and Basic Investigations into Smith-Lemli-Opitz Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1998-CH-0081
Smith-Magenis syndrome	07-HG-0076	A Phase One Treatment Trial of the Circadian Sleep Disturbance in Smith-Magenis Syndrome (SMS)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-HG-0076
Smith-Magenis syndrome	01-HG-0109	Natural History Study of the Clinical and Molecular Manifestations of Smith-Magenis Syndrome (SMS)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-HG-0109
Soft tissue sarcoma	10-C-0120	A Phase I Study of Pazopanib as a Single Agent for Children with Relapsed or Refractory Solid Tumors, including CNS Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0120
Spasmodic dysphonia	08-N-0181	Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia and Other Focal Dystonias	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-N-0181
Spasmodic dysphonia	05-N-0189	Neuropathological Basis of Spasmodic Dysphonia and Related Voice Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-N-0189
Spasmodic dysphonia	92-DC-0178	Multimodal Studies of Language Production and Comprehension in Normal Volunteers and Patients with Neurologically-Based Language Impairments	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1992-DC-0178
Spasmodic dysphonia	85-N-0195	A Training Protocol for the use of Botulinum Toxin in the Treatment of Neurological Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1985-N-0195
Spastic paraparesis	04-N-0071	Phase I/II Study of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Using the Humanized MiK-Beta-1 Monoclonal Antibody Directed Toward the IL-2/IL-15R-Beta Subunit (CD122) that Blocks IL-15 Action	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-N-0071
Spinocerebellar ataxia	08-N-0134	Pilot Study of Tolerability of Lithium Therapy in Patients with Spinocerebellar Ataxia Type I (SCA1)
Splenomegaly	08-I-0053	Pilot (Phase I-II) Study of Valproic Acid (Depakote) for the Treatment of the Autoimmune Lymphoproliferative Syndrome (ALPS)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-I-0053
Splenomegaly	07-C-0130	A Phase 1, Multicenter, Dose-Escalation Study of CAT-8015 in Patients with Relapsed or Refractory Hairy Cell Leukemia (HCL)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0130
Splenomegaly	04-C-0121	A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Chronic Lymphocytic Leukemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-C-0121
Spondylarthropathy	03-AR-0131	Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-AR-0131
Squamous cell carcinoma of the head and neck	10-D-0180	A Pilot Trial Targeting mTOR as a Novel Mechanism-Based Neoadjuvant Therapy for Head and Neck Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-D-0180
Squamous cell carcinoma of the head and neck	08-C-0071	Phase I Study of Bortezomib and Cetuximab without or with Cisplatin in Combination with Radiation Therapy for Advanced Head and Neck Cancer
Squamous cell carcinoma of the head and neck	01-C-0104	A Phase I Study of Concomitant Therapy with Proteasome Inhibitor PS-341 and Radiation in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Still's disease adult onset	05-AR-0014	Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects with Autoinflammatory Disease: A Therapeutic Approach to Study Pathogenesis
Stomach carcinoma	09-C-0189	Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0189
Stomach carcinoma	95-HG-0165	Outcomes of Education and Counseling for HNPCC / Lynch Syndrome Testing	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-HG-0165
Stomach carcinoma	07-C-0111	A Pilot Study of Markers of Tumor Burden and Radiation Toxicity in the Blood, Urine, and Stool of Patients Receiving Radiotherapy for Gastrointestinal Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-C-0111
Subcutaneous panniculitis-like T-cell lymphoma	09-C-0065	Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in T and NK-Cell Lymphomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0065
Subcutaneous panniculitis-like T-cell lymphoma	09-C-0243	A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-Ribose) Polymerase and Temozolomide in Children with Recurrent/Refractory CNS Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0243
Subcutaneous panniculitis-like T-cell lymphoma	10-C-0105	A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children with Gliomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-C-0105
Sydenham's chorea	89-M-0006	Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Controls	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-M-0006
Synovial sarcoma	11-C-0113	A Pilot Study of Genetically Engineered NY-ESO-1 Specific (c259) T cells in HLA-A2+ Patients with Synovial Sarcoma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0113
Synovial sarcoma	08-C-0080	SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0080
Synovial sarcoma	00-C-0092	A Randomized Trial of Filgrastim-SD/01 vs. Filgrastim in Newly Diagnosed Children and Young Adults with Sarcoma Treated with Dose-Intensive Chemotherapy
Synovial sarcoma	09-C-0054	A Group Wide Biology and Banking Study for Phase II Study of R1507	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-C-0054
Synovitis	00-AR-0222	Studies of the Pathogenesis and Natural History of Arthritis and Related Conditions	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-AR-0222
Synovitis	94-HG-0105	Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-HG-0105
Synovitis	07-AR-0146	Analysis of Stored Identified Specimens from Patients Enrolled in Protocol Number 98-AR-0150
Syringomyelia	01-N-0085	Establishing the Pathophysiology of Primary Spinal Syringomyelia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-N-0085
Syringomyelia	00-N-0089	Genetic Analysis of the Chiari I Malformation	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-N-0089
Syringomyelia	10-N-0143	A Prospective Natural History Study of Patients with Syringomyelia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-N-0143
Systemic capillary leak syndrome	09-I-0184	Studies in the Pathogenesis of Systemic Capillary Leak Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-I-0184
TAR syndrome	02-C-0052	Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0052
Testicular cancer	02-C-0178	Multidisciplinary Etiologic Study of Familial Testicular Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2002-C-0178
Tetanus	01-I-0226	Evaluation of Immune Response to Vaccines in Primary Immune Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0226
Thalassemia	09-H-0225	Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Beta-Thalassemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0225
Thalassemia	06-H-0202	Cardiopulmonary Function Assessment and NO Based Therapies for Patients with Hemolysis-Associated Pulmonary Hypertension
Thalassemia	03-H-0170	Non-Myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation For Severe Congenital Anemias Including Sickle Cell Disease, Thalassemia, and Diamond Blackfan Anemia	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-H-0170
Thalassemia	04-H-0161	Studies of the Natural History of Sickle Cell Disease and Other Hemolytic Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-H-0161
Thalassemia	85-H-0087	Clinical Course of Patients with Transfusional Hemochromatosis on Deferoxamine
Thyroid cancer, anaplastic	11-C-0027	A Phase I/II Trial of Crolibulin (EPC2407) plus Cisplatin in Adults with Solid Tumors with a Focus on Anaplastic Thyroid Cancer (ATC)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0027
Tick-borne encephalitis	09-I-0246	A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-Borne Encephalitis (TBE) for NIAID Workers Manipulating Tick-Borne Encephalitis Virus (TBEV) in the Laboratory	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-I-0246
Tongue cancer	10-D-0180	A Pilot Trial Targeting mTOR as a Novel Mechanism-Based Neoadjuvant Therapy for Head and Neck Cancer	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-D-0180
Trichinosis	77-I-0094	Study of Patients with Parasitic Infections of the Gastrointestinal Tract	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1977-I-0094
Trichotillomania	96-M-0124	Genetics of Obsessive-Compulsive Disorder: A Collaborative Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1996-M-0124
Tuberculosis	01-I-0202	Natural History, Genetics, Phenotype and Treatment of Mycobacterial Infections	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2001-I-0202
Tuberculosis	10-I-0195	Training Protocol on the Natural History of Tuberculosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-I-0195
Tuberculosis	06-I-0030	Correlation of the Precursor Frequency of CD4 + Effector Memory T Cells with Induration Measured in the Tuberculin Skin Test (TST)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2006-I-0030
Tuberous sclerosis	08-H-0177	Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (The MILES Trial)
Tuberous sclerosis	00-H-0051	Cutaneous Tumorigenesis in Patients with Tuberous Sclerosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-H-0051
Tuberous sclerosis	96-H-0100	Role of Genetic Factors in the Pathogenesis of Lung Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1996-H-0100
Tuberous sclerosis	95-H-0186	Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1995-H-0186
Tuberous sclerosis	10-CH-0084	Studies of Autistic Patients: Gene Networks and Clinical Subtypes	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-CH-0084
Tuberous sclerosis	08-H-0016	Effect of Fasting on the Size of Lymphangioleiomyomas in Patients with Lymphangioleiomyomatosis	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-H-0016
Turner syndrome	07-EI-0145	Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome and Premature Ovarian Failure	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2007-EI-0145
Turner syndrome	00-CH-0219	Turner Syndrome: Genotype and Phenotype	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-CH-0219
Urethral cancer	11-C-0140	A Phase I Study of Gemcitabine, Carboplatin and Lenalidomide (GCL) for Treatment of Patients with Advanced/Metastatic Urothelial Carcinoma (UC) and Other Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-C-0140
Usher syndrome	05-EI-0096	Natural History and Genetic Studies of Usher Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-EI-0096
Usher syndrome	05-EI-0143	Molecular Genetics of Retinal Degenerations	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2005-EI-0143
VACTERL association	08-HG-0224	Clinical and Genetic Studies of VACTERL Association	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-HG-0224
Van der Woude syndrome	0	Shigella Sonnel O-SPC/rBRU Conjugate Vaccine
Von Hippel-Lindau syndrome	08-C-0020	A Phase 2 Study of ZD6474 (Vandetanib) in Patients with Von Hippel Lindau Disease and Renal Tumors	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0020
Von Hippel-Lindau syndrome	04-C-0238	A Phase II Study of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Von Hippel Lindau Disease and Renal Tumors
Von Hippel-Lindau syndrome	98-C-0139	Vaccine Therapy with Tumor Specific Mutated VHL Peptides in Adult Cancer Patients with Renal Cell Carcinoma
Von Hippel-Lindau syndrome	03-C-0145	Evaluation of the Natural History and Management of Pancreatic Lesions Associated with Von Hippel-Lindau	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2003-C-0145
Von Hippel-Lindau syndrome	00-N-0140	A Prospective Natural History Study of VHL Patients with CNS Hemangioblastomas	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-N-0140
Von Hippel-Lindau syndrome	00-CH-0093	Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-CH-0093
Von Hippel-Lindau syndrome	99-C-0053	Von Hippel-Lindau (VHL) Disease Genetic Epidemiology Study	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1999-C-0053
Von Hippel-Lindau syndrome	89-C-0086	Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1989-C-0086
WAGR syndrome	08-CH-0213	WAGR Syndrome and Other 11p Contiguous Gene Deletions: Clinical Characterization and Correlation with Genotype	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-CH-0213
Waldenstrom macroglobulinemia	09-H-0094	A Pilot Study of the Safety and Efficacy of Escalating Doses of ON 01910.Na in Patients with Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-H-0094
Wells syndrome	94-HG-0105	Genetics and Pathophysiology of Familial Mediterranean Fever and Related Disorders	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1994-HG-0105
WHIMS	09-I-0200	A Phase I Study of Mozobil (TM) in the Treatment of Patients with WHIMS	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2009-I-0200
Williams syndrome	10-M-0112	Defining the Brain Phenotype of Children with Williams Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2010-M-0112
Wilms' tumor	08-C-0051	A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-C-0051
Wilson disease	91-DK-0214	Evaluation of Patients with Liver Disease	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1991-DK-0214
Wiskott Aldrich syndrome	08-HG-0059	Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2008-HG-0059
Wiskott Aldrich syndrome	04-HG-0226	Investigations of Megakaryocytes from Patients with Abnormal Platelet Vesicles	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2004-HG-0226
Wiskott Aldrich syndrome	00-HG-0209	Molecular and Clinical Studies of Primary Immunodeficiency Diseases	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2000-HG-0209
Zollinger-Ellison syndrome	11-DK-0114	A Pilot Trial of YF476, A Gastrin Antagonist, in Patients with Type II Gastric Carcinoids Associated with Zollinger-Ellison Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?2011-DK-0114
Zollinger-Ellison syndrome	90-DK-0137	Evaluation of the Gastrinoma in Patients with Zollinger-Ellison Syndrome	http://clinicalstudies.info.nih.gov/cgi/show_detail.cgi?1990-DK-0137